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EZH2! was! reported! to! be! aberrantly! expressed! in! gastric! cancer! (GC).! Its!
deregulation! was! shown! to! suppress! GC=related! tumor! suppressor! genes.!
Inhibition! of! EZH2! expressions! by! genetic! (RNAi)! or! pharmacologic! (DZNep)!
means! significantly! suppressed! the! growth! of! a! subset! of! GC! cells.! We! found!
DZNep!sensitivity!in!gastric!cancer!is!strongly!associated!with!p53!genomic!status,!
with! p53$ wild=type! (p53=WT)! lines! being! more! sensitive! (P<0.001).! We!
demonstrate!a!novel!p53=related!mechanism!in!DZNep!cellular!sensitivity!at!least!
in! cultured! GC! cells! involving! EZH2=USP10=p53! using! knockdown! techniques.!
Finally,!we! showed!EZH2!expression! is!negatively! correlated!with!p53!pathway!
activation!in!primary!GC!tissues.!Our!results!highlight!a!potentially!important!role!
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of! the! gastric! cancer! cases! are! adenocarcinomas! originating! in! mucosa! (inner!
lining! of! the! stomach)! (1).! 4%! of! GC! are! attributed! by! slowEglowing! mucosaE
associated! lymphoid! tissue! (MALT)! lymphoma.! 3%! of! GC! are! carcinoid! tumors!
originating! from! hormoneEmaking! cells! of! stomach! in! neuroendocrine! system.!!
Moreover,! gastrointestinal! stromal! tumors!are! rarer!and! they!are!originated! in!
interstitial!cells!of!Cajal!in!the!wall!of!the!stomach.!In!this!thesis,!we!will!focus!on!
discussing! adenocarcinoma! of! GC! as! this! GC! type! accounts! for! nearly! all! GCE
related! death.! So,! in! the! remaining! thesis,! GC! is! referring! to! gastric!
adenocarcinoma!only.!GC!is!defined!into!proximal!and!distal!according!to!the!site!
of!cancer!origin.!Cancer!develops!near!the!gastroEesophageal!junction!is!defined!





!!Gastric! cancer! is! the! fourth! most! common! worldEwide! malignancy! and! the!
second!leading!cause!of!cancer!death!accounting!for!700,000!deaths!annually!(2,!
3).!Its!incidence!rates!vary!geographically.!The!majority!of!cases!(over!78%)!occur!






(Figure! 1.1).! Japan! and! Korea! have! the! highest! gastric! cancer! incidence! ratesE











The! incidence! of! gastric! cancer! for! men! of! all! ages! is! highest! in! developing!















!!Due! to! its! asymptomatic! characteristic,! gastric! cancer! remains! a! disease!with!
poor!prognosis!and!high!mortality.! ! In!a!study!on!high!risk!populations! in!Chile,!






socioEeconomic! class,! poor! prognosis! and! survival! when! compared! with! distal!
tumors! which! are! common! in! developing! countries! (12).! However,! the!
management!of!both!variants!is!identical,!with!cisplatin!and!fluorouracil!as!major!
components!of!combination!therapy!regime!for!GC!treatment!worldwide.!Due!to!
the! distinct! etiology,! history! and! biological! behavior! between! the! two! GC!
variants,!with! a!higher! risk!of! early!hematogenous! spread! in!proximal!GC! (13),!
the! two! variants! respond! differently! to! the! same! treatment! regimen.! Other!












!!Several! attempts! were! made! for! GC! classification.! They! include! the! Ming!
classification,!which!is!based!on!growth!pattern!and!Lauren’s!classification,!which!
is!based!on!various!predominant!histological!pattern!(11).!Lauren’s!classification!
is! the!most!widelyEused!and!accepted!approach! to! classify!GC!as! it!has!proven!
useful! in! evaluating! the! natural! history! of! GC! (11).! In! Lauren’s! classification,!
gastric! cancer! is! classified! into! two! subtypes:!Diffuse! type! (50%)! and! Intestinal!
type! (35%)! according! to! their! clinical! histology.! Diffuse! tumors! are! poorly!
differentiated,! they! infiltrate! and! thicken! the! stomach! wall;! Intestinal! variants!




et+ al.,! intestinal! GC! follows! a! model! of! sequential! steps! in! cancer! formation!
starting! from! atrophy! (loss! of! glands),! intestinal!metaplasia! (transformation! of!
stomach! epithelium! to! intestinal! features! of! the! appearances! of! globlet! cells),!
dysplasia!and!then!finally!carcinoma!(15).!However,!diffuse!GC!does!not!seem!to!
follow!this!model.!In!addition,!distal!and!proximal!tumors!are!usually!associated!










!!Gastric! cancer! is! a! multiEfactorial! disease.! Its! pathology! is! associated! with!





the!World! Health! Organization’s! International! Agency! for! Research! on! Cancer!
(IARC)!(16).!!
++H.+Pylori!are!gramEnegative!bacilli!colonizing!the!stomach!of!over!half!of!world’s!
population! (17).! Geographic! variation! of!H.+ Pylori! exists! (Figure! 1.2).! Countries!
with! high! gastric! cancer! rates! such! as! those! in! Asia! typically! have! a! high!
prevalence!of! infection.!For!example,!90%!of!asymptomatic!adults!over!the!age!
of! 20! in! Korea! are! H.+ Pylori! carriers! (3).! Infection! is! usually! acquired! during!
childhood! by! oral! ingestion! and! is! highly! associated! with! low! socioeconomic!
status! (18,! 19).! The! prevalence! of!H.+ Pylori! infection! is! significantly! associated!
with! gastric! cancer! incidence! (3,! 20).! They!may!promote!gastric! carcinogenesis!
either! by! silencing! the! functions! of! tumor! suppressors! (see! chapter! 1.3)! or!
inducing!chronic!inflammatory!responses.!!
!!!!A!high! intake!of!salty!food!and!NEnitroso!compounds!and! low!intake!of! fresh!
fruits!and!vegetables!increase!the!risk!of!H.+Pylori! infection,!gastritis!and!gastric!









!!The! stomach! produces! abundant! gastric! juice! containing! concentrated!






!!Individuals! with! polymorphisms! of! proEinflammatory! cytokines! such! as! ILE1b,!
TNFEα!and!ILE8!suffer!a!higher!risk!of+H.+Pylori!infection!and!also!intestinal!GC!but!
not!diffuse!GC!carcinogenesis.!The!polymorphisms!lead!to!a!higher!production!of!
these!cytokines,!which! inhibit!acid!secretion! in! the!stomach.!A! transgenic!mice!
model! overexpressing! ILE1b! has! a! thicker! gastric! mucosa,! lower! level! of! acid!
production!and!as!a!consequence,!resulting!in!severe!gastritis!followed!by!typical!
intestinalEGC!associated!atrophyEintestinal!metaplasiaEdyplasiaEadenocarcinomas!




































++p53,!RUNX3! and+CDH1! are! important! tumor!suppressor!gene! (TSGs)!and! their!






transcription! factor! organizing! stressEinduced! cellular! responses! including!
apoptosis,! cell! cycle! arrest,! senescence,! DNA! repair,! cell! metabolism! and!
autophagy!by!activating!specific!target!genes!(26).!Thus,!p53!functions!to!prevent!
uncontrolled!growth.!p53!protein!consists!of!transactivation!domain!(TAD)!at!the!
N! terminus,! the! core!DNA!binding!domain! (DBD)! ! and!also! the! tetramerization!
domain!(Tet)!at!C!terminus!as!illustrated!in!Figure!1.3.!!
!!Under! normal! physiological! conditions,! p53! protein! level! is! low! under! the!
control! of! a! complicated! regulatory! network! (Figure! 1.4)! and! mainly! by! postE
translational!modifications! (27).! The!major! regulation! is! contributed! by!MDM2!
(26).!MDM2!is!an!E3!ubiquitin!ligase;!upon!binding!to!p53,!MDM2!ubiquitinates!
on! N! terminus! and! DBD! of! p53,! which! is! then! sent! for! proteasomeEmediated!
degradation! (28,! 29).! ! Under! stress! conditions,! an! ATM! pathway! is! activated,!






phosphorylated! residues! subsequently! inhibit! MDM2Ep53! interaction! (30)!
leading!to!p53!stabilization.!!!!!
!!Once! stabilized,! p53! is! activated! through! various! postEtranslational!
modifications! such!as! acetylation!on! lysine! residues!382!by!p300/CBP! (31)! and!
also! removing! of! SET8Einduced!methylation! on! the! same! residues! (32,! 33).! In!
general,! acetylation! on! p53! activates! while! methylation! lead! to! functional!
activation! or! repression! of! p53! depending! on! the! type! of!methylation! and! the!




!!After! stabilized! p53! is! activated,! it! translocates! into! the! nucleus! and! binds! to!
subsets!of!hundreds!of!p53!target!genes!with! the!specific!DNA!binding!domain!
(28).!This!leads!to!various!cellular!responses!including!apoptosis,!cell!cycle!arrest!
or! senescence! (36)! (Figure! 1.5).! ! Specific! response! is! determined! by! p53!
regulating! context! after! DNA! damage.! p53! target! genes! have! variable! p53!
binding!affinity! leading!to!different!threshold! levels! for!their!activation.!Serious!
DNA!damage!results!in!p53!accumulation!to!higher!levels,!which!could!overcome!
low! affinity! binding! threshold! on! some! apoptotic! genes.! In! addition,! DNA!
damage! causes! some! postEtranslational! modifications! on! p53! and! affects! p53!
interaction!with!other!cofactors.!Mayo!LD,!et+al.!have!identified!phosphorylation!






p53! binding! cofactors! also! affect! the! selection! of! target! genes! of! p53.! For!
example,!members!of!the!ASPP!family!facilitate!but!iASPP!inhibit!transactivation!
of! apoptotic! genes! by! p53.! Overall,! many! factors! contribute! to! the! decision!
making!process!such!as!(i)!the!type,!time!and!extent!of!the!DNA!damage,!(ii)!cell!
type,!(iii)!extracellular!stimuli,!(iv)!cellular!proliferative!potential,!(v)!efficiency!of!
DNA! repair! and! (iv)! the! ratio! of! proEapoptotic! to! antiEapoptotic! factors! in! the!
cells!(38).!
!!!As!shown!in!Figure!1.4,!HAUSP/USP7!is!another!p53!regulator.!Li!M.!et+al.!and!
Kon!N.!et+al.! demonstrated! the!dynamic! role!of!USP7!both! in+ vitro! and! in+ vivo!




higher! affinity! under! normal! unstressed! condition.! MDM2Ebound! USP7!
deubiquitinates!and!stabilizes!MDM2,!promoting!p53!degradation.!Under!various!
stresses,!USP7!binding!to!p53! is!more!preferable!and!USP7!plays!a!role! in!p53E
mediated!cellular! responses! (42).!Recently,! TSPYL5! !was! shown! to! interact!and!
inhibit!the!activity!of!USP7!(43).!The!biological!function!of!TSPYL5!may!depend!on!
the!USP7!function,!which!could!potentially!deubiquitinate!p53!or!MDM2.!Thus,!
TSPYL5! may! confer! an! oncogenic! function! by! suppressing! p53,! meanwhile,!
TSPYL5! may! also! possess! tumor! suppressor! functions! by! reducing! the! MDM2!








!!!!In! addition! to!what! have! been! shown! in! Figure! 1.4,! recently,! there! are! two!
proteins!found!to!participate!in!the!complicated!network!of!p53!regulation.!They!
are!USP10!and!also!NUMB.!USP10!is!another!newly!identified!p53!deubiquitinase!
after! USP7.! CoEexpression! of! USP10! and! MDM2! counteracts! the! ubiquitinase!
activity!of!MDM2!and!leads!to!p53!stabilization!(45).!In!addition,!NUMB!controls!
p53! by! inhibiting! E3! ubiquitinase! activity! of! MDM2! without! perturbing! the!
primary! interaction! between! MDM2! and! p53! in! a! tricomplex.! Loss! of! NUMB!
expression! is! suggested! to! be! associated! with! lung! cancer! and! also! basalElike!
breast!cancer!(46,!47)!while!USP10!is!downregulated!in!renal!cell!carcinoma!(45).!
Expression! of! USP10! and! NUMB! in! most! of! the! cancer! types! including! gastric!
cancer!remains!largely!unknown.!
!!Loss! of! p53! activity! benefits! cancer! growth.! p53! is! one! of! the! frequently!
mutated! tumor! suppressor! genes! in! cancer! (~50%! for! all! cancer! types).! In! all!
cancers,! the!majority!of!p53!mutation! is!missense! (74%).! !Around!a! third!of!all!
missense!mutations! arise! in! six! hotspot! residues:! 175,! 245,! 248,! 273,! 249! and!










(52E54).! Mutated! p53! protein! also! conveys! a! gainEofEoncogenic! function! by!
binding! to! and! regulating! the! activity! of! various! cellular! proteins! including!p63!
and!p73.!These!two!proteins!have!been!shown!to!confer!some!potential!tumor!
suppressive! functions! although! their! functions!may! not! be! equivocal! (55).! p63!
and!p73!were!also!shown!to!be!required!by!p53!to!activate!a!few!proapoptotic!
genes!in!mouse!embryo!fibroblasts!expressing!E1A!(56).!!
!!According! to! p53!website,! around! 45%!of! gastric! cancer! carried!mutated!p53!
(57).!Indeed,!there!are!significant!differences!of!p53!mutation!frequencies!from!
different! studies.! This! could! be! due! to! different! techniques! to! identify! the!
mutations! such! as! immunohistochemical! techniques! and! different! sequencing!
methods.! The! immunohistochemical! techniques! involved! p53! antibodies! with!
various! epitopes! and! this! assessment! involved! subjective! assessment.!
Meanwhile,! those! sequencing! studies! had! various! detection! sensitivity! and!
covered!different!regions!of!p53!gene,!mostly!on!exon!5E8!(58).!It!is!controversial!





































Figure( 1.6.( Distribution( of( p53( somatic( mutations( according( to( IARC( TP53(
mutation(database.!!
A.!Pei! chart! showing! the!prevalence!of!different!mutation! types! to!p53.!B.!The!
distribution!of! reported!missense!mutations!along!393!aminoEacid! sequence!of!
p53.!The!six!most!common!hotspot!mutations!are!highlighted!in!yellow!for!DNAE
contact! mutations,! green! for! locally! distorted! mutants! and! blue! for! globally!
denatured!mutants.!The!bottom!part!is!a!schematic!diagram!showing!the!domain!
architecture! of! p53.! PR,! prolineErich! domain;! Reg,! carboxyEterminal! regulatory!





RuntEDNA! binding! domain! (63).! A! study! showed! the! absence! of! RUNX3!
expression! in! around!44%!of!GC! (64).! Primary! tissues! and!mouse!models! have!
shown!the!significance!between!RUNX3!inactivation!and!gastric!cancer!formation!
and! progression! (64,! 65).! Early! reports! suggested!RUNX3! is! lost!mainly! due! to!
chromosomal!deletion!and!promoter!hypermethylation!in!gastric!cancer!(64).!!In!












transmembrane!glycoprotein! family! responsible! for! calcium!dependent! cellEcell!
adhesion.! It! is! commonly! expressed! in! all! epithelial! cells! to! establish! and!
maintain! polarization! and! differentiation! through! intracellular! adhesion!
complexes! (67).! Mutation! of! CDH1! is! common! in! the! diffuse! type! of! gastric!
cancer! type! (30E40%)! but! not! in! the! intestinal! type! (68,! 69).! CDH1! mutation!
carriers!appear!normal!until!their!second!copies!are!inactivated!(70).!!Epigenetic!
silencing! especially! DNA! methylation! on! CDH1! is! the! major! inactivation!
mechanism!for! the!second!copies!where!mutation! is! relatively! rare! (71,!72).!H.+
Pylori! infection! is! associated! with! hypermethylation! on! CDH1! (73).! Loss! of! EE
Cadherin! results! in! loss! of! cell! adhesion! and!promotes! cell!motility! and! cancer!
migration!and!invasion!(74,!75).!!
!!Gastric! cancer! is! usually! a! lateEonset! disease.! However,! a! study! showed! that!
patients!with!early!onset!GC!are!asymptomatic!carriers!of!germEline!mutations!of!












sequence! change.! The! two!major!epigenetic!mechanisms!are!DNA!methylation!
and! histone! modifications.! Interplay! among! DNA! methylation! and! histone!
modifications!regulate!chromatin!structure!together!(77).!Modifications!on!DNA!
or!histones!recruit!enzymes!responsible!for!other!epigenetic!machineries!leading!
to! establishment! and! maintenance! of! chromatin! status.! Aberrant! epigenetic!
states! are! common! in! cancers.! Due! to! the! reversible! nature! of! epigenetic!





!!DNA! methylation! is! a! process! in! which! methyl! groups! are! added! to! the! 5’!
position! of! the! nucleotides! Eusually! to! the! base! cytosine! right! after! guanine!
(called! CpG! site)! leading! to! gene! silencing.! ! In! human! genome,! normally,! only!
about!1%!sequence!is!CpG!rich,!so!called!CpG!island!(78).!Roughly!about!half!of!
the! CpG! islands! are! associated! with! promoter! regions! (79).! DNA! methylation!
could!occur!at!both!CpG!islands!and!also!nonECpG!rich!region!(80E82).!Thus,!there!
are! two!main! patterns! of! DNA!methylation:! global!methylation! and! promoterE









There! are! four! DMNTs! found:! DMNT1,! for!methylation!maintenance! following!
DNA! replication.! DMNT3A! and! 3B,! for! de! novo! methylation! on! unmethylated!
sites! (85).! DMNT2,! for! some! de! novo! CpG! methylating! capacity(86).! Aberrant!
methylation! of! tumor! suppressor! genes! (TSGs)! such! as! SFRP1! and! MHL1! is! a!
fundamental!abnormality! in!many!cancers!by!epigenetic!silencing!or!promoting!
inactivation! mutation! of! tumor! suppressor! genes! (81).! ! Schuebel! KE.! et+ al.!
showed! the! incidence!of!hypermethylation!on! some!potential! TSGs!was!higher!
than! that! of! mutations! in! breast! and! colon! cancer! cells,! that! were! probably!
having!hypermethylation!phenotype.! !They!also!found! larger!numbers!of!genes!
hypermethylated!compared!with!mutation!in!these!cancers!(87).!These!findings!
suggest! that! the! aberrant! methylation! may! contribute! significantly! to!
tumorigenesis.!!
!!Apart! from! silencing! TSGs,! aberrant! hypermethylation! involves! in! high!
mutagenicity.! 5’Emethylated! cytosine! is! a! mutable! site! by! undergoing!
spontaneous! deamination! to! thymine! (88)! whose! transition! frequency! is! 10!
times! higher! than! others.! Due! to! the! inefficiency! of! the! G:T! specific! repair!
mechanism,!such!mutations!are!allowed! to!accumulate! in! specific! cancer! types!







is! strong! coincidence! of! hotspot!mutation! (codon! 248,! 273)! of! p53! gene! with!
GC:AT!transition!(91).!!
!!Despite!the!exponentially! increasing! identification!of!genes!under! influence!of!
aberrant! DNA! methylation! in! cancer,! it! is! not! fully! clear! how! tumors! acquire!
hypermethylation! during! their! development.! One! potential! mechanism! is! the!
aberrantly!high!expression!of!DNMTs!selected!in!cancer.!Several!studies!analyzed!
the! expression! levels! of! DNMTs! in! human! tumors! and! cell! lines! at!mRNA! and!
protein! levels.! Several! reports! showed! that! DNMTs! appeared! to! be!
overexpressed!when! their! expression! levels!were! normalized! by! housekeeping!
gene!such!as!GAPDH!but!the!significant!higher!DNMTs!expression!was!abolished!
when! corrected! by! cell! proliferation! marker! expressions! (92,! 93).! Their!
upregulations!might! be! a! simple! reflection! of! increased! cell! proliferation.! This!
was! further! supported! by! another! study! in! lung! cancer! (94)! And! some! studies!
demonstrated! a! clear! association! between! the! overexpression! of! DNMT1! and!
3A/B!and!tumorigenesis!of!some!cancer!types!(95E98).! In!addition,!a!decreased!
expression! of! DNMT1! and! 3B! was! also! observed! in! cancers! such! as! serous!
endometrial!carcinoma!(99,!100).!DNMT2!expression!was!usually!reported!to!be!
decreased! in! cancer! (101).!More! investigation! is! needed! to! investigate! for! any!
causal! relationship!between! specific! types!of!DNMTs! in!each! specific! cancer.! It!










!!Another! possible! contributing! factor! for! hypermethylation! is! environmental!





induces! hypermethylation! effects! in! lung! and! liver! cancers! in! rodent! models!
probably! by! stabilizing! and! accumulating! DNMT1! protein! (106)! (Figure! 1.7).!
These!evidences!suggested!that!hypermethylation!acquired!in!tumor!may!be!due!
to!environmental!changes!or!exposure!to!risk!factors.!This!is!also!in!line!with!the!









via( AKT( pathway( possibly( leading( to( promoter( hypermethylation( and(
tumorigenesis.((
NNK! from! cigarettes! activates! AKT! by! phosphorylation.! Phosphorylated! AKT!
inactivates! GSK3β! by! phosphorylation! at! Ser9,! which! subsequently! attenuates!
the! degradation! of! DNMT1! by! nuclear! βEtransducin! repeatEcontaining! protein!
(βTrCP).! Meanwhile,! phosphorylated! AKT! ! phosphorylates! heterogeneous!
nuclear! ribonucleoprotein! U! (hnRNPEU)! and! promotes! its! interaction! with!
nuclear! βTrCP! to! free! DNMT1! from! binding! by! degradative! nuclear! βTrCP.!
DNMT1! is! thus,! allowed! to! stabilize! and! bind! to! promoters! of! multiple! TSGs!






analogs,!which! are! phosphorylated! by! uridine/cytidine! kinase! inside! cells,! thus!







trap! DNMTs,! hence! the! global!methylation! reduces! (111)! (Figure! 1.8! and! 1.9).!
The!nonEspecific!effects!of!DMNT! inhibitors!have!systemic! toxic!effects! such!as!
myelosuppression! (112).! Thus,! dosage! optimization! of! DMNT! inhibitors! is!
important! for! clinical! use! in! order! to! maximize! the! efficacy! but! minimize! the!
toxicity.! A! study! has! demonstrated! that! the! efficacy! of! 5Eazacitidine! in!
myelodysplastic! syndromes! and! leukemia! is! mediated! by! the! reactivation! of!
cyclin! dependent! kinase! inhibitor,! p15,! which! is! usually! silenced! by! promoter!
methylation!(113).!The!possibility!of!using!5Eazacitidine!and!decitabine!as!a!single!
or! combined! treatment! for! solid! tumor! is! still! under! investigation! by! many!
research!groups!(114)!
!!Several! reports!demonstrated!normal! fibroblasts!or!epithelial! cells! are!usually!
less!affected!by!DNMTs!compared!with!cancer!cells! (115E117).!There!are!a! few!
possibilities!to!address!the!preferential!effects!of!DNMTs.!!First,!some!TSGs!were!
aberrantly! silenced! by! hypermethylation! in! cancer! cells! and! this! methylation!
aberration! is! selected! during! cancer! development! (118)! (118).! For! example,!
Cheng!JC.!et+al.!observed!that!a!DNMTi!inhibited!the!growth!of!cancer!cells!were!
likely! due! to! the! upregulated! expression! of! p21.! They! observed! that! p21!
expression! was! ! silenced! in! cancer! cells! while! it! was! expressed! in! all! the!
fibroblast!cells! tested!(115).!Thus,!cancer!cells!with!aberrantly!silenced!p21!are!
more! sensitive! to! the! loss! of! methylation.! Second,! they! also! suggested! the!
preferential!effects!of!a!DNMTi,!zebularine,! for!cancer!cells! that!were!probably!














Figure( 1.8.( Effects( of( 5Sazacytidine( on( DNMTsSmediated( conversion( to( 5’S
methyl(cytosine.!!
Cytosine!is!converted!to!5’methyl!cytosine!by!DNMTs!with!a!methyl!group!(CH3)!










Z,! DNMT! inhibitors! are! cytosine! analogs,! which! are! phosphorylated! and!
incorporated! into!chromosomal!DNA!as! if!other!natural!cytosine!during!cellular!
SEphase.! The! analogs! in! DNA! regions! form! covalent! bond! with! DNA!
methytransferases,! resulting! in! active! enzyme! depletion! and! also! global!








chromosomal! DNA! is! wrapped! around! them! (Figure! 1.10A).! LysineErich! tails!
protrude! from! each! of! the! histone! component! and! they! are! subjected! to!
reversible!post! translational!modifications! (Figure!1.10A!and!B).!Different! types!
of! modifications! on! different! site! by! specific! enzymes! lead! to! the! opening! or!
closing! of! chromatin! structures! and! subsequently! gene! activation! or! silencing.!








!!Histone! acetyltransferase! (HAT)! and! histone! deacetylase! (HDAC)! are! the! two!
enzymes,! which! are! responsible! for! acetylation! and! deacetylation! respectively!
(Figure!1.10B).!!!
!!Acetylations! on! histone! lysine! residues! by! HAT! such! as! CBP/p300! result! in!
transcriptional! activation! (122).! Acetyl! group! is! negatively! charged,! thus,!
acetylation!could!neutralize!the!positive!charges!on!the!histone!tails.!The!charge!




loosening! the! highly! organized! chromatin! structure! alone! is! necessary! but! not!
sufficient! (124).! A! recruitment! model! demonstrated! acetylElysines! by! HAT! on!
histone!tails!create!a!new!binding!site!for!other!chromatin!modulators!including!
bromodomainEcontaining! proteins! such! as! P300/CBPEassociated! factor! (PCAF)!
(125).!The!transcriptional!activation!effect!of!acetylation!is!indeed!contributed!by!
the!synergistic!actions!of!multiple!recruited!factors!(126).!!
!!Genetic! studies! showed! the! aberrations! of!HATs!have!both! tumor! suppressor!
and! oncogene! functions! in! cancer.! For! example,! missense! and! deletion!
mutations! in! p300! are! found! in! colorectal,! gastric,! and! brain! cancers.! On! the!
other! hand,! CBP! is! found! translocated! to! MORF! resulting! in! a! fusion! protein!






inhibitors! such! as! curcumin! and! garcinol! acid! have! demonstrated! antiEcancer!
effects!possibly!through!multiple!mechanisms!(125)!.!
!!Histone!acetylation!status!is!governed!by!highly!dynamic!interplay!between!HAT!
and! HDAC.! HDAC! reverses! the! acetylation,! removes! the! charge! neutralization!
effect! and! closes! up! the! chromatin! structure! for! genetic! transcription! (127).!
HDACs!are!consisted!of!18!family!members,!which!are!classified!into!class!I,!II,!III!
and! IV!according!to!their!sequence!similarity.! !Class! I,! II!and! IV!are!regarded!as!




focus!of! the! field!of!histone!deacetylases.! !The!molecular! function!and!roles!of!
the!classic!HDACs!are!summarized!in!Table!1.1.!!
!!Most!of!the!HDACs!family!proteins!are!overexpressed!in!cancers!compared!with!
normal! tissues! except! HDAC10! and! HDAC11.! For! example,! HDAC1! is!
overexpressed! in! 60%! gastric! cancer! compared! with! normal! tissue.! The!
functional!study!results!of!each!HDAC!are!summarized!in!Table!1.2.!Knockdown!
of! HDACs! inhibited! cancer! features! by! inducing! autophagy,! apoptosis,!
senescence,!growth!inhibition!and!sensitizes!cell!for!chemotherapy!as!reviewed!
by!Witt!O.!et+al.!(Table!1.2!and!Figure!1.11,!(128,!129)).!It!should!be!noted!that!










Figure( 1.10.( Schematic( diagram( of( A.( histone( structure( in( nucleosomes;( B(NS
terminal(tails(protruding(from(core(histones!
!K,! Lysines! are! potential! acetylated/deacetylated! sites! for! histone!
acetyltransferase! (HAT)! and!histone!deacetylase! (HDAC);!A,!Acetyl;! C,! CarboxyE




































!!HDAC! inhibitors! inhibit! HDAC! by! binding! into! the! active! site! pocket! and!
chelating!the!catalytic!zincEion!located!at!its!base,!hence,!preventing!HDAC!from!









clinical! use!on!patients!with! cutaneous! TEcell! lymphoma! (129).!As! a! pan!HDAC!
inhibitor,!vorinostat!inhibits!class!I,!II!and!IV!HDAC!unselectively.!Not!surprisingly,!
first!phase!I!and!II!studies!of!vorinostat!demonstrated!sideEeffects!including!bone!
marrow! depression,! diarrhea,! weight! loss,! taste! disturbances,! electrolyte!







hematological! malignancies.! There! are! potent! inhibition! effects,! selectively! to!
HDAC1! or!HDAC1! and! 2! in! Class! I! compared!with! the! effects! on! other!HDACis!
(Table! 1.3).! Although! class! I! HDACi! demonstrated! similar! clinical! efficacy,!


















was! represented!by!netting.!The!hydroxamic!acid!moiety!of! SAHA!binds! to! the!
zinc!at!the!bottom!of!the!catalytic!pocket.!The!burying!of!most!of!the!structure!of!
SAHA! into! the! active! site! of! HDAC! prevents! HDAC! from! binding! to! its! natural!
















histone! proteins! with! a! certain! degree! of! site! overlap! with! acetylation.! Lysine!
residues!can!be!monoE,!diE!and!triEmethylated!on!their!amine!groups!depending!
on! the! specificity! of! the! lysine!methyltransferases! (KHMTs)! (Figure! 1.13A).! On!
the!other!hand,!arginine!residues!can!accommodate!up!to!two!methyl!moieties!






1.14)(134).! HMT! are! very! specific! enzymes! which! modify! residues! at! some!
specific!sites!to!specific!degrees,!that!is,!in!different!methylation!states!(134).!As!
shown! in!Figure!1.14,!each!site! is!methylated!by!specific!enzymes! for!example,!
H3K27!is!modified!by!E(Z)!whereas,!H3K4!is!modified!by!mixedElineage!leukemia!
(Trithorax! homolog),! (MLL).! In! general,! methylated! H3K4,! H3K36,! H3K79! are!
hallmarks!for!active!transcriptional!units,!whereas,!methylated!H3K9,!H3K27!and!







or! chromatin! modifying! enzymes! to! the! chromatin! for! further! transcriptional!
regulation! (Figure! 1.15).! For! example,! Polycomb!protein! complex! (PRC1! or! PC)!




(137).! There!are! two! types!of!PRMTs:! type! I! and! type! II! responsible! for!Rme1s!
(symmetric! monomethylated! arginine),! Rme2s! (symmetric! dimethylated!
arginine),! and! Rme1as! (asymmetric! monomethylated! arginine)! and! Rme2as!
























































!!Previously,! histone! methylation! were! considered! to! be! permanent! and!
irreversible! as! the! turnover! of! histone! and! lysine!methylation!within! them!are!
the!same,!as!reported!in!the!1970s(135).!In!2004,!the!first!arginine!demethylase,!
PADI4! (139,! 140)! and! lysine! demethylase,! LSD1! (141,! 142),! were! identified.!!
Subsequently,!JMJD6!is!found!to!remove!methyl!group!from!methylated!arginine!
in!a!mechanism!different!from!PADI4!via!hydroxylation!reaction!(143).!!
!!Lysine! specific! demethylase!1! (LSD1)! is! an!H3K4! specific! demethylase!utilizing!
FAD!as! a! coEfactor.! It! removed! the!monoE! and!diEmethylation!only! but! not! triE
methylation! as! it! requires! a! protonated! nitrogen! for! demethylation! reactions!
(134).! Binding! to! CoEREST! repressor! to! form! a! complex! is! essential! for! LSD1E
mediated! demethylation! on! nucleosomal! histones! as! CoEREST! confers!
nucleosomal! recognition! to! LSD1! (135).! The! associated! partners! indeed!
determine!the!specificity!of!LSD1!action!and!thus,!the!result!of!LSD1!action.!For!
example,!when! LSD1! is! associated!with! androgen! receptor! instead!of! CoEREST,!
LSD1! demethylates! H3K9,! which! is! a! repressive! mark! leading! to! genetic! reE
activation.!!In!contrast,!demethylation!of!H3K4!results!in!repression(144).!!!











highly! specific! to! their! target! lysine!at!particular!position!and!even! the! level!of!
methylation.! For! example,! JMJD2! demethylates! only! H3K9me2/3! and!
H3K36me3/2! (134,! 135).! Other! demethylases! identified! include! UTX/JMJD3,!!








Reaction! mechanism! of! lysine! demethylation.! (Top)! Methylated! moiety! is!
removed!from!monomethylated! lysine!by! JmjC!domainEcontaining!demethylase!
protein!(KDM)!using!Fe!(II)!and!αEketoglutarate!(2OG)!as!coEfactors.!The!reaction!
yields! unmethylated! lysine! and! also! by! products,! CO2! and! succinate.! (Bottom)!
KDM1/LSD1! removes! methyl! group! using! FAD! as! coEfactor! and! yield!
unmethylated!lysine!and!by!products,!H2O2,!FADH2.!The!ribbon!structure!on!the!











!!Polycomb! Repressive! Complex! 2! (PRC2)! is! the! major! enzyme! complex!
responsible!for!triEmethylating!H3K27,!leading!to!a!silent!heterochromatin!state!
(134).! PRC2! is! structurally! similar! in! human! and! drosophila! by! having! a! highly!
conserved! catalytic! subunit! (88%),! EZH2! (enhancer! of! zeste! homolog! 2)! in!
humans!or!E(Z)! in!drosophila!(Figure!1.16,(137)).!EZH2!and!E(Z)!are!SETEdomain!
containing!proteins!responsible!for!the!methyltransferase!activity!of!the!complex!
(155).! However,! EZH2/E(Z)! subunit! carry! out! its! catalytic! activity! only! when! it!
binds! to! the!other! two!proteins,!SUZ12!and!EED/ESC! (155,!156)! (Figure!1.17A).!!
Figure!1.16B!shows!the!domain!organization!where!SUZ12!and!EED/ESC!binds!to!
EZH2/E(Z)!and!the!enzymatic!SET!domain!is!at!the!NEterminal!of!the!structure.!!
!!PRC2! functions! to! regulate! differentiation! and! proliferation.! It! is! well! known!
that! PRC2! initiates! transcriptional! silencing! of! differentiation! genes! including!
HOX! genes! in! early! development! of! Drosophila! (157,! 158).! Later! discovery!
demonstrates! EED! of! PRC2! is! playing! a! role! in! initiating! XElinked! chromosomal!
inactivation!in!embryonic!cells,!which!is!important!to!maintain!cellular!stemness!!
(159).! Knockdown! experiments! demonstrated! EZH2! is! essential! for! cellular!
proliferation! in! both! transformed! and! untransformed! cells.! Its! expression! is!
tightly! regulated!by!pRBEE2F!pathway(160).!EZH2! in!PRC2! is! reduced! in!cellular!
senescence! and! this! allows! transcription! in! INK4aEARF! locus,! whose! encoded!
proteins! are! the! primary! regulators! of! senescence! (161).! Chen! et+ al.! recently!






(162).! CyclinEdependent! kinases! (CDK)! 1! and! 2,! whose! functions! in! cell! cycle!
control! are! well! studied! were! found! to! phosphorylate! EZH2! at! Threonine! 350!
(Thr350)! in!an!evolutionarily! conserved!motif.! This!phosphorylation! is!essential!
for! EZH2! recruitment! and! maintenance! of! H3K27me3! at! target! loci! of! EZH2.!







copy! number! was! reported! (164E166).! EZH2! overexpression! was! shown! to! be!
associated! with! aberrant! silence! of! CDH1! and! RUNX3! in! gastric! cancer! (160).!
Similar! alterations! were! also! found! in! breast! cancer! (167,! 168).! The! causal!
relationship! between! EZH2! and! these! TSGs! were! further! supported! by! the!
finding! that! knockdown! of! EZH2! reactivated! these! two! gastric! cancerErelated!
tumor! suppressor! genes! (167E169).! These! evidences! demonstrated! the! classic!
model!of!how!aberrantly!high!EZH2!level!promoted!tumorigenesis;!where!EZH2!









!Emerging! evidences! show! that! the! high! EH2! expression! intervenes!with!many!
pathways!in!promoting!cancer!development.!For!example,!in!EREnegative!breast!
cancer!cells,!EZH2!was!found!to!promote!growth!and!modulate!BRCA1Emediated!
proliferation! effects.! The! tumor! suppressor! BRCA1! involves! in! DNA! repair! and!
cell! cycle! checkpoint! regulation! as! well! as! the! maintenance! of! chromosomal!
stability!(171).!Several!studies!found!that!the!activation!of!akt!protein!regulated!
BRCA1! stability! and! shuffling! (172E175).! Recently,! Gonzalez! ME.! et+ al.! linked!
these! prior! findings! together! and! demonstrated! that! high! EZH2! expression! in!
breast! cancer! induced! AKTEdependent! genomic! instability! and! BRCA1! shuffling!
inhibition!(176).!The!newly!reported!EZH2Emediated!activation!of!AKT!implicated!
a!possibility!that!they!may!work!together!to!promote!tumor!mobility.!Both!EZH2!
and! AKT! proteins! in! cytosol! regulate! actin! organization! (177E179).! Further!
investigation!is!needed!to!understand!if!any!relationship!between!these!proteins!















while! EZH2/E(Z)! are! the! enzymatic! component! with! SET! domain.! Association!
between!PRC2!and!PHF1/PCL! is!essential! for! the!PRC2!activity(182).!B.!Domain!
organization!of!EZH2/E(Z).!EZH2/E(Z)!protein!posses!five!functional!domains.!SET!
domain! contain! enzymatic! active! site! and! CXC! domain! also! contribute! to!
enzymatic! activity.! EED/ESC! and! SUZ12! bind! to! EID! domain! and! domain! II! of!
EZH2/! E(Z)! respectively! for! robust! enzymatic! activity! of! PRC2.! %! above! each!
















!!Aberrant! expressions! of! HMTs! and! HDMs! in! cancer! implicate! potential!
therapeutic!target!for!cancer!therapy.!There!are!no!histone!methyltransferase!or!
demethylase! inhibitors! in! any! clinical! trial.! However,! there! are! two! analogues!
developed! to!be! specifically! against! LSD1!or! JMJD2.!Use!of! these! inhibitors! for!
the!treatment!of!colon!cancer!cells!retard!cellular!proliferation!(183,!184)!.!!More!
intensive!study!of!these!compounds!is!needed!for!their!antiEcancer!effects.!!
!!There! are! also! two! inhibitors! reported! to! target! histone! methyltransferases,!
they!are!3Edeazaneplanocin!A! (DZNep)!as!EZH2! inhibitor!and!BIXE01294!as!G9a!
inhibitor! (185).!DZNep! is! a!potent! SEadenosylhomocysteine! (AdoHcy)!hydrolase!




!!DZNep! was! firstly! developed! as! a! small! molecule! with! antiEviral! activity! by!
inhibiting!viral!RNA!maturation!(187).! In!2007,!DZNep!was!found!to!be!the!first!
pharmacological! agent! which! could! deplete! each! subunits! of! PRC2! including!
EZH2!by!proteasomal!degradation!and!thus!reducing!the!associated!H3K27me3!
level.!More! intriguingly,! DZNep! causes! selective! apoptosis! to! breast! and! colon!
cancer!cells!but!not!normal!epithelial!cells!(188).!This!paves!the!way!for!further!
characterization! of! DZNep! in! other! cancers.! Subsequently,! Miranda! TB.! et+ al.!






induce! other! histone! marks! such! as! H3K9me2! and! H3K79me3! in! addition! to!
H3K27me3!(189).!Despite!of! the!nonEspecific!activity,!DZNep! is!a!wellEaccepted!
EZH2! inhibitor! and! inhibits! proliferation! in! leukemia! (190),! ! breast! (191)! and!











on! gastric! cancer! cells.! With! the! evidence! of! high! EZH2! expression! in! gastric!
cancer! (164),!We!hypothesized!DZNep!may! inhibit! the!growth!of!at! least! some!

















































!!Gastric! cancer! cell! lines! and! MCF7! cells! were! purchased! from! vendors! or!
obtained! from! collaborators.! AGS! and! Hs746T! cells! were! purchased! from! the!
American!Type!Culture!Collection!and!AZ521,!Ist1,!TMK1,!MKN1,!MKN7,!MKN74,!
and! IM95! cells! were! obtained! from! the! Japanese! Collection! of! Research!
Bioresources/Japan! Health! Science! Research! Bank.! YCC1,! YCC3,! YCC6,! YCC7,!
YCC10,!YCC11,!and!YCC16!cells!were!gifts!from!Dr.!SunEYoung!Rha!(Yonsei!Cancer!
Center,!South!Korea),!and!MCF7!cells!were!from!Dr.!Alexandra!Pietersen!(DukeE
NUS,! Singapore).! Cells! were! cultured! in! either! RPMI! or! Minimum! Essential!
Medium! of! Eagle! (MEM)! or! Dulbecco’s! Modified! Eagle! Medium! (DMEM)!
supplemented! with! 10%! Fetal! Bovine! Serum! (FBS)! (Life! technologies,! USA),!
0.1mM! MEM! NonEEssential! Amino! Acids! Solution,! 2mM! LEGlutamine! and! 2%!
PenicillinEStreptomycin! (Invitrogen!Corporation,!USA).!All! cells!were!grown! in!a!
humidified! incubator! with! 5%! CO2! at! 37oC.! All! cells! are! adherent! cells.!
Subculturing!of!cells!was!performed!using!0.25%!trypsin!(Invitrogen!Corporation,!
USA)! to! detach! and! split! ! at! the! ratio! from! 1:4E1:10! and! maintained! as! the!
method!described!above.!!







DZNep!dissolved! in!DMSO,!or!DMSO!only! (control)! for!24,!48!and/or!72!hours.!
For! molecular! assays,! cells! were! treated! with! 5uM! DZNep! unless! otherwise!
specified.!!




!!All! cells! were! preserved! in! liquid! nitrogen.! Cell! suspension! in! medium! was!
mixed! with! 5%! DMSO! (Sigma,! USA).! Cells! were! aliquoted! into! 2ml! plastic!
cryogenic! vial! (IWAKI,! Japan).! The! cryovials! were! put! into! a! Cryo! Freezing!





of! diluted! cell! suspension! was! mixed! with! equal! volume! of! Trypan! Blue!
(Invitrogen!Corporation,!USA).!10ul!stained!cells!were!loaded!into!each!chamber!













!!Cell! proliferation! assays! were! performed! using! a! CellTiter96! Aqueous!
Nonradioactive! Cell! Proliferation! Assay! kit! (Promega,! USA)! following! the!
manufacturer's!protocol.!It!is!a!colorimetric!method!for!determining!the!number!
of! viable! cells! in! proliferation! or! chemosensitivity! assays.! The! kit! contains!
solutions! of! a! novel! tetrazolium! compound! [3E(4,5EdimethylthiazolE2Eyl)E5E(3E
carboxymethoxyphenyl)E2E(4Esulfophenyl)E2HEtetrazolium,! inner! salt;! MTS]! and!
an!electron!coupling!reagent!(phenazine!methosulfate;!PMS).!MTS!is!bioreduced!
by!cells!into!a!purple!formazan!product!that!is!soluble!in!tissue!culture!medium.!
The! absorbance!of! the! formazan! at! 490nm!can!be!measured!directly! from!96E
well! assay! plates! without! additional! processing.! The! conversion! of! MTS! into!
aqueous,!soluble!formazan!is!accomplished!by!dehydrogenase!enzymes!found!in!
metabolically!active!cells.!The!quantity!of!formazan!product!as!measured!by!the!
amount! of! 490nm! absorbance! is! directly! proportional! to! the! number! of! living!
cells!in!culture.!
!!Before!proliferation!assay,!cells!were!seeded!at!concentrations!of!1E5×103!cells!
per! well! in! 96Ewell! plates.! After! desirable! experimental! end! points,! 20ul! MTS!
reagent!was!added!to!each!well.!After! four!hour!of! incubation!at!37oC,!cellular!







experiments! were! repeated! for! at! least! three! independent! times.! GI50! was!
calculated! by! the! formula:! [(TdET0)/(CET0)]! x! 100! =! 50]! using! absorbance!





Cells! after! DZNep/DMSO! treatment! for! 24! hours! were! harvested! and! fixed! in!
cold!80%!ethanol!in!phosphate!buffered!saline!(PBS)!for!12!hours!at!E20!oC.!After!
ethanol!removal,!fixed!cells!were!resuspended!in!600ul!PI!solution!(25mg/ml!PI,!




!!Apoptotic! populations! were! determined! using! Annexin! VEFITC/7EAAD! kit!
(Beckman! Coulter,! Inc.,! USA)! according! to!manufacturer's! protocol.! Cells! were!
harvested!and!spined!down!at!15000!rpm!for!5!mins! to! remove!medium.!Cells!
were! washed! and! incubated! in! cold! 100ul! 1X! binding! buffer! containing! 5ul!
Annexin!VEFITC!solution!and!10ul!7EAAD!viability!dye!for!15!min!in!the!dark!and!
on!ice.!Stained!cell!suspension!were!topped!up!to!500ul!with!1X!binding!buffer!
and! analyzed! by! flow! cytometry! on! a! Beckman! Coulter! Cytomics! FC! 500!











!!Cells!were!washed! twice!with! PBS! and! fixed!with! freshly! prepared! 3.7%! (v/v)!
formaldehyde!in!PBS!for!5!mins,!washed!twice!and!incubated!with!XEgal!staining!
solution!(1mg/ml!5EBromoE4EchloroE3Eindolyl!βEDEgalactoside!(XEgal;!Sigma,!USA),!
40mM! citric! acid/sodium! phosphate! buffer! (pH! 6.0),! 5mM! potassium!
ferricyanide,!5mM!potassium!ferrocyanide,!150mM!NaCl,!and!2mM!MgCl2)!at!37!
oC!for!overnight!.!Color!photographs!of!stained!cells!were!acquired!in!bright!field!









on! ice! for! 30!mins! in! 0.5%!NPE40! buffer! (50mM! TrisHCl! (pH! 8.0),! 1mM! EDTA,!
0.3MNaCl,!10%!glycerol,!1mM!DTT,!0.5%!NPE40!complemented!with!proteinase!
inhibitor!and!halt!phophatase!inhibitor!(Thermo!Scientific!Pierce,!UK!).!Cells!were!






collected! as! total! cell! lysates! and! immediately! frozen! in! nitrogen! liquid,!which!
were!then!transfered!and!stored!in!E80oC!freezer.!!
!!Cells! on! each! well! (6! well! format)! for! ubiquitin! assays! were! lysed! in! 1! ml!
ubiquitinEpreserving! buffer! (20X! stock! was! made! of! 2.5ml! 2Emercaptoethanol,!
10.43ml!water,! 0.5ml!50%!glycerol,! 10ml!10%!SDS,! 1.56ml!1M!Tris! pH!6.8! and!
0.0025g!bromophenol!blue).!!



























!!The! SDSEPAGE! gel! was! performed! using! a! MiniEPROTEAN! 3! Electrophoresis!
System!(BioErad!Laboratories,!USA).!Two!concentrations!of!SDS!gels!were!used!in!
this! study! depending! on! the! molecular! size! of! the! protein! to! be! detected.!
Proteins!with!size!>40KDa!and!those!<40Kda!were!separated!by!8%!and!15%!gels!
respectively.! Briefly,! separating! gels! were! prepared! by! mixing! appropriate!
amount!of!30%!acrylamide/!bisacrylamid!solution! (37.5:1;!BioErad!Laboratories,!






on! top! of! the! separating! gel.! 5%! stacking! gel! was! the! mixture! of! 0.5ml! 30%!









(pH! 6.8),! 10%! glycerol,! 2%! SDS,! 0.05%! bromophenol! blue)! and! 2.5%! of! 2E
mercaptoethanol!was!added!right!before!boiling! in!99oC!heat!block! for!5!mins.!
Samples! were! allowed! to! cool! down! and! loaded! to! each! well! of! SDS! gels.!








1X! transfer! buffer:! prepared! by! 1:10! 10X! TrisEGlycineESDS! PAGE! buffer,! 2:10!
100%!Methanol!and!7:10!water.!Gel!was!then!placed!in!between!layers!of!filter!
membrane! (Millipore,! USA),! Whatman! papers! and! foam! pads! (BioErad!
Laboratories,! USA)! and! put! into! holder! cassettes! in! electrode! assembly! with!











membrane! was! then! incubated! with! ! 1:500E1:1500! primary! antibodies! in! SEA!
Block!Buffer!(Thermo!Scientific,!USA)!for!overnight:!Mouse!monoclonal!antiEEZH2!
(AC22),! antiESZU12! (D39F6),rabbit! monoclonal! antiEγH2A.X! (20E3),! rabbit!
polyclonal! phosphoEp53! (ser15)! (Cell! signaling! Technology,! Inc.,! USA),! rabbit!
polyclonal! antiEEED,! mouse! polyclonal! antiEtrimethylEhistone! H3! (lys27)!
(Millipore! Corporation,! USA),! ! mouse! monoclonal! antiEp14! (14P02),! rabbit!
polyclonal! antiEp16! (Thermo! Scientific,! USA),! mouse! polyclonal! antiEUSP10!
(Abcam,!UK),!mouse!monoclonal!antiEp21!(FE5),!p53!(DOE1),!MDM2!(SMP14),!βE
actin! (ACTBD11B7),! rabbit! polyclonal! FAS! (CE20)! and! GADD45α! (HE165)! (Santa!
Cruz!Biotechnology,!Inc.,!USA).!Membranes!were!then!washed!with!0.1%!Tween!
20! in! PBS! for! 10!mins.! After! washing! for! three! times! of! washing,!membranes!
were! incubated!with!1:15000!secondary!antibodies! in!SEA!Block!buffer! for!one!
hour:! ! Goat! antiEmouse! IgG! (H+L)EDyLight! 800! conjugated,! goat! antiErabbit! IgG!
(H+L)EDyLight! 680! conjugated! and! donkey! antiEgoat! IgG! (H+L)EDyLightE800!
conjugated!antibodies!(Thermo!Scientific!Life!Science,!UK)!depending!on!the!host!
origin!of!the!primary!antibodies.!After!washing!for!three!times,!immunoblotting!




!!Mouse! polyclonal! antiEp53! (DOE1)! or! mouse! IgG! antibodies! (Santa! Cruz!
Biotechnology,! Inc.,!USA)!were!added!into!2mg!cleaned!lysates!for!overnight!at!








were! washed! for! three! times! with! immunoprecipitation! buffer.! The! washed!
beads!were!then!resuspended!in!1X!western!blot! loading!buffer,!boiled!at!95oC!
for!5!mins!and!processed!for!SDSEPAGE!electrophoresis,!gel!transfer,!membrane!
blocking! and! immunoblotting! using! HRPEconjugated! mouse! monoclonal! antiE
MDM2! (SMP14)! or! antiEp53! (FL393)! antibodies! (Santa! Cruz! Biotechnology,Inc.,!
Santa!Cruz,!CA,!USA).! Signals!were!detected!using!ECL! substrate,! Fast!Western!




ChIP! assays!were! carried!out!using! the!EZEZyme!Chromatin!Prep!Kit! (Millipore,!
MA,! USA)! was! used! following! the! manufacturer’s! protocol.! Briefly,! chromatin!
was! crossElinked!with! 1%! formaldehyde! for! 10!min! at! room! temperature;! this!
was!followed!by!quenching!with!glycine!and!DNA!fragmentation.!The!equivalent!
of! 106! cells! was! used! for! each! immunoprecipitation.! The! nuclear! lysate! was!
precleared!for!1!hour!with!protein!G!magnetic!beads!and!incubated!overnight!at!
4oC!with!protein!GElinked!magnetic!beads!and!2ug!of!ChIP!validated!antibodies!
(Millipore,! MA,! USA)! to! EZH2.! Enrichment! of! EZH2! binding! was! evaluated! by!
qPCR! using! 1/50! of! the! immunoprecipitated! chromatin! as! template! and! the!






sequences! of! USP10! upstream! region:! Forward:5’EGGGGATCTAATGCGAACACT;!
Reverse:5’EGAGAGGGCAGGCAGGTAGAG! and! USP10! downstream!





heated! lysates! were! loaded! to! stacking! gel! on! top! of! 8%! separation! gel! and!
electrophoresis,! gel! transfer,! membrane! blocking! and! immunoblotting! were!
performed!using!HRPEconjugated!mouse!monoclonal!antiEp53!(FL393)!antibody.!






cell! pellets! were! resuspended! and! disrupted! in! buffer! RLT.! Lysates! were!
homogenized! in! a! QiaShreddar! spin! column! (Qiagen,! Netherlands).! FlowE!
through!were!mixed!with!equal!volume!of!70%!ethanol!and!passed!through!RNA!











!!!cDNAs! were! synthesized! using! a! SuperScript! III! FirstEStrand! Synthesis! Kit!






































!!Microarray! hybridizations! were! performed! using! Affymetrix! Human! Genome!
U133! plus! Genechips! (HGEU133! Plus! 2.0,! Affymetrix,! USA)! according! to! the!
manufacturers'! instructions.! Raw! data! obtained! after! chipEscanning! was!
processed! using! the! RMA! algorithm! (Affymetrix,! USA)! in! the! Bioconductor!
package! simpleaff.! For! primary! gastric! samples,! a! cohort! of! 192! tumors! were!
collected! with! approvals! from! National! Cancer! Centre,! Singapore,! Research!
Ethics! Review! Committee! and! with! signed! patient! informed! consent,! and!
available! from! GEO! under! accession! number! (GSE15460).! Expression! and! p53!













added! to! 200ul! resuspended! cells! in! PBS.! 200ul! Buffer! AL! was! added! and! the!
mixture! was! incubated! at! 56oC! for! 10! mins! after! thoroughly! mixing.! 200ul!









!!Exons!1E11!of!p53!were!amplified!by!PCR! in!20ul! volumes! containing!20ng!of!
total!DNA,!1!unit!Platinum!Taq!DNA!polymerase! (Invitrogen!Corporation,!USA),!
0.3mM!dNTP!mixture,!1X!PCR!buffer!and!0.3uM!of!forward!and!reverse!primers.!
PCR! conditions! were:! 95oC! for! 10min,! amplification! for! 39! cycles! at! 95! oC! for!


























!!Specific! siRNA! targeting! EZH2! mRNA! with! the! following! sequence:! 5′E
cggtgggactcagaaggcaE3′!was!described!previously!(195)!and!synthesized!by!Sigma!
(SigmaEAldrich!Corporate,!St.!Louis,!MO,!USA!).!USP10!siRNAE1!were!purchased!
from! Dharmacon! (Lafayett,! CO,! USA),! targeting! 5’EtgagtttggtgtcgatgaaE3’! of!
USP10.! The! nonEtargeting! control! siRNA! was! purchased! from! Dharmacon!
(Lafayette,! CO,! USA).! Reagent! siPORT! was! used! as! a! transfection! reagent! and!
purchased! from! Ambion! Inc.,! USA.! Transfection! was! performed! according! to!
manufacturer’s!protocol.!Briefly,! 5ul! siPORT! transfection! reagent!was!added! to!







diluted! into! 100ul! OptiEMEM.! Diluted! siPORT! transfection! reagent! was! mixed!
with! diluted! siRNA! and! incubated! for! 10! mins! at! room! temperature! to! allow!
transfection! complexes! to! form.! Transfection! complexes! were! dispensed! into!
clean!wells!on!6!well!plates!and!overlayed!with!2!ml!cell! suspension! in!growth!





pClSEco( Retrovirus( Packaging( Vector:! pCl! vector! backbone! contains! the!






pClSAmpho( Retrovirus( Packaging( Vector:! It! belongs! to! pCl! vector! system! and!
shares! the! same! architect! as! shown! in! Figure! 2.1.! Instead,! its! env! element!
encodes! amphotropic! viral! envelop! proteins,! which! allow! infection! to!







pRetroSuper( (pRS)( Vector:! pRetroSuper! (pRS)!was!described!by!Brummelkamp!





















!!pCAmphotropic,! pEcotropic! retrovirus! packaging! vectors,! ecotropic! receptor!
expressing! retrovirus! constructs,! pRS! empty! vector! and! pRSEp53! constructs!
(target:! GACTCCAGTGGTAATCTAC)! were! kindly! provided! by! Dr.! Mathijs!
Voorhoeve! (DukeENUS,! Singapore).! For! retroviral! infections,! a! total! of! 15ug!
plasmids! consisted! of! 5ug! pAmpho! vector! and! 10ug! ecotropic! receptor!
expressing!construct!or!5ug!pEco!vectors!and!10ug!pRS!vector/pRSEp53!construct!
plasmids! following! a! standard! calcium! phosphate! protocol! (197)! were! mixed.!
Briefly,! 500ul! 2X! HBS! buffer! (pH! 7.05)! stock! (! 8.0! g! NaCl! 6.5! g! HEPES,! 10! ml!
Na2HPO4!stock!solution!(5.25!g!in!500!ml!of!water)!in!500!ml)!was!added!to!the!
plasmid!mix.!100ul!calcium!chloride!(CaCl2)!was!added!to!the!plasmidEbuffer!mix!










either! the! empty! vector! (pRSEEV)! or! p53! knockdown! vector! (pRSEshp53).! Only!
mammalian! cells! expressing! ecotropic! receptors! could! be! transduced! by! the!




!!Gastric! cancer! cells!were! first! transduced!with! the! thawed!ecotropic! receptor!
expressing! construct! carrier! retroviral! supernatants! together! with! 8ug/ml!
polybrene!(Sigma,!USA)!for!12!hours!and!maintained!in!normal!cultural!medium!
for!24hrs.!Transduced!cells!were!then!selected!by!50ug/ml!G418!(Invitrogen,!USA)!
for! 14! days.! They! were! then! transduced! with! thawed! pRSEEV/pRSEshp53!






!!A!previously!described!p53!signature! (KANNAN_P53! (198))!was!obtained! from!







there!were!KANNAN_p53_UP!and!KANNAN_p53_DN! signature.! ! The! signatures!
were! consisted! of! the! primary! p53! target! genes! which! were! upregulated! or!
downregulated! with! the! introduction! of! p53! in! human! lung! cancer! cell! line.!!
These!primary!targets!include!genes!involved!in!not!only!cell!cycle!and!apoptosis!





are! largely! overlapping,!we!would! like! to! predict! p53! pathway! activity! of! each!
gastric! cancer! tissue! given! the! tissue’s! expression! levels! of! the! p53! signature.!
Due! to! the!multivariate!nature!of! the! independent!variables,!we!applied!a!p53!
pathway! activity! analysis! based! on! Bayesian! Factor! Regression!Models! (BFRM)!
(http://www.stat.duke.edu/research/software/west/bfrm/)! (200).! The! purpose!
of!BFRM!is! to!come!up!with!an!equation!that! fits! through!the!cluster!of!points!
with!minimum!amount!of!derivation!from!the!best!fit!model:!
X!=!u!+!AF!+!e!!









underlying! latent! factor,! which! could! be! considered! as! “pathway! activities”.!
Briefly,!BFRM!started!with!the!seed!signature!of!p53!and!generated!a!regression!
model! in! which! the! genes’! expression! levels! are! a! function! of! a! latent! factor.!
BFRM!then!expands! the!model!by!adding! further!genes! that!also!appear! to!be!
associated! with! the! latent! factor! and! then! refits! the! model.! We! used! the!
activation! scores! to! determine! the! final! activation! status! of! the! p53! pathway.!























































in!primary!gastric! cancer! tissues!at!protein! levels! (83!pairs)!and!RNA! levels! (22!
pairs)!in!three!independent!studies!done!by!Matsukawa!Y.!et+al.!and!Mattioli!E.!
et+ al.! (201)! using! immunohistochemistry! method! ! and! Fuji! S.! et+ al.+ using!
quantiative!realEtime!PCR+!respectively!(168).!!!
!!As! these! studies! were! performed! on! relatively! small! patient! populations,! we!
sought! to! independently! confirm! these! observations! in! a! larger! cohort.!!
Examining!EZH2!transcript!levels!with!data!from!whole!genome!gene!expression!
microarray!experiment!of!100!primary!normal!and!192!cancerous!gastric!samples,!
captured!by!microarray!method! (Table!3.1!provides! clinical! characteristics),!we!
confirmed! that!GC!express! significantly! elevated! EZH2! transcripts! compared! to!
normal! tissues! (p<0.001)! (Figure! 3.1A).! Specifically,! 90%! of! gastric! tumors!
exhibited!higher! EZH2!RNA!expression! levels! above! the!mean!EZH2!expression!
level! of! 100! normal! gastric! tissues.! There! is! no! published! data! about! the!








SUZ12! and! EED! respectively! when! compared! to! the! mean! of! the! 100! normal!
gastric!tissues!(p<0.001)!(Figure!3.1B!and!3.1C).!!



































EZH2! (A),! SUZ12! (B)! and! EED! (C)! mRNA! expression! levels! in! primary! normal!












compared! with! normal! mucosa! at! both! RNA! and! protein! levels! (164).! They!
showed!eight!out!of! thirteen!GC! cell! lines! expressing!elevated!EZH2! compared!
with! normal!mucosa! using! real! time! PCR! and! also!western! blotting.! There! is! a!
significant!correlation!between!the!RNA!and!protein!expressions!of!EZH2!in!the!
13!cell!lines!in!their!studies.!!




samples.!To!confirm!that!EZH2! is!also!highly!expressed! in!GC! in+vitro,!here,!we!
examined! the!EZH2! transcript! levels! in! sixteen!GC!cell! lines!by! looking! into!our!












!!These! results! demonstrated! that! EZH2! is! indeed! highly! expressed! in! the!



























mixed! type! is! more! heterogeneous,! we! compared! the! EZH2,! SUZ12! and! EED!
expression! between! diffuse! (n=75)! and! intestinal! types! (n=99)! of! gastric!
adenocarcinoma!only.!All!EZH2,!SUZ12!and!EED!were!significantly!expressed!in!a!
higher!level!in!intestinal!types!than!in!diffuse!types.!As!shown!in!figure!3.3A,!79%!
of! (78/99)! intestinal! types! of! GC! expressed! significantly! higher! expression! of!
EZH2!transcripts!compared!with!the!mean!of!75!diffuse!samples!(p<0.001).!This!
is!consistent!with!earlier!report!by!Mattioli!E.!et+al.!(201)!!where!they!identified!
79%! (37/47)! of! gastric! cancer! as! high! EZH2! group! by! immunohistochemistry!
method!and!they!showed!significant!correlation!between!EZH2!expression!with!














Figure( 3.3.( EZH2,( SUZ12( and( EED( mRNA( expression( levels( between( primary(
diffuse(and(intestinal(gastric(cancers.(
AEC.! EZH2,! SUZ12! and! EED! expression! levels! in! primary! diffuse! (n=75)! and!
intestinal! (n=99)! gastric! cancers.! EZH2! SUZ12! and! EED! are! highly! expressed! in!



























!!!We! investigated! the! effects! of! DZNep! on! EZH2,! SUZ12! and! EED! and! their!
associated! mark! in! gastric! cancer.! We! directly! applied! a! working! condition! of!
DZNep! from! a! breast! cancer! study! to! our! experiments! (188,! 189).! And! we!
performed!the!titration!experiment!in!GC!later!to!confirm.!We!hypothesized!that!
the!concentration!would! likely!be!relevant! in!other!epithelial!cancer!cells! (such!
as! GC)! apart! from! breast! cancer.! The! same! working! concentration! was! later!
adopted!by!other!epithelial!cell!studies!(189,!204).!We!treated!16!GC!cells! lines!
with!5uM!DZNep!for!72!hours.!We!then!extracted!the!total!cell!lysates!from!the!












levels! of! EZH2,! SUZ12! and! EED! in!DZNepEtreated! samples!with! those! in!DMSO!
control! samples! in! all! 16! GC! cells! lines! (Figure! 3.4).! Consistent! with! existing!
reports!by!Fiskus!W.!et+al.!and!Tan!J.!et+al.!!(190,!202),!DZNep!treatment!reduced!
EZH2,! SUZ12!universally! in!all! 16!GC! lines! to! various!extents!depending!on! the!
individual! cellular! context.! There! was! a! concomitant! reduction! of! associated!























Figure( 3.4.( Effects( of( DZNep( on( EZH2,( SUZ12,( EED( depletion( and(
trimethylated(H3K27((H3K27me3)(in(GC(cell(lines.(
Protein! expression! levels! of! EZH2,! SUZ12,! EED! and! H3K27me3! in! DZNepE





















pharmacological! avenue! to! deplete! EZH2.! The! first! paper! investigating! the!
phenotypic!effects!of!DZNep!in!cancer!illustrated!that!DZNep!can!cause!selective!
growth! inhibition! on! multiple! cancer! cell! lines! including! MCF7,! RKO,! SW480!
(colon! cancer),! Hep3B! (liver! cancer)! and! DU145! (prostate! cancer)! but! not! on!
normal! epithelial! cells.! Subsequently,! more! studies! demonstrated! that! DZNep!
treatment! resulted! in! growth! inhibition! of! multiple! cancers! including! acute!
myeloid!leukemia!(190),!prostate!cancer!cells!(188).!However,!only!two!cell!lines!
were! used! as! representative! in+ vitro! models! for! these! studies.! NCI! has! also!
screened!sensitivity!of!DZNep!against!60!cancers!from!10!origins!including!breast,!
leukemia! and! lung! etc.!
(http://dtp.nci.nih.gov/docs/misc/common_files/cell_list.html).! Most! of! the!
cancers! exhibited! heterogeneous! growth! inhibition! to! DZNep! treatment.!!
Although! there! are! increasing! evidences! showing! heterogeneous! growth!
responses!in!cancers!such!as!breast!cancer!(192)!and!multiple!myeloid!leukemia!
(203),!not!much!is!known!about!DZNep!sensitivity!in!gastric!cancer.!!
!!We! then! investigated! into! the! growth! inhibitory! effects! of! DZNep! on! gastric!
















measured! at! 24! hours,! 48! hours,! 72! hours! and! 96! hours! after! the! initial! cell!
seeding.!24!hours!after!cell!seeding!was!defined!as!T0!while!48,!72!and!96!hours!
postEseeding!were!defined!as!Tt24,!48!and!72!respectively.!Cells!were!cultured!in!
normal! culture! medium.! Colorimetric! MTS! assays! were! performed! and!
absorbance!was!measured!at!each!time!point.!Hence,!the!more!active!the!cells!




!!Figure! 3.5A! demonstrates! the! proliferation! rates! of! YCC1! cell! line! at! Tt24,! 48!
and! 72! in! three! different! starting! cell! densities! (1000,! 3000! and! 5000).!






showing! that! these! cells! were! growing! exponentially.! Comparing! proliferation!
rates!at!Tt24!with!different!cell!seeding!density,!YCC1!cells!seeded!at!3000!cells!
demonstrated! higher! proliferation! rate! than! 1000! cells! because! of! higher! cell!
seeding!density.!However,!the!proliferation!rate!of!cells!seeded!at!5000!cells!was!
lower!than!3000!or!1000!cells.!This! is!probably!due!to!contact! inhibition!of! the!
cells.!There!was!no!increasing!proliferation!rate!at!the!different!time!point!when!
YCC1! cells!were! seeded! at! 3000! cells! or! 5000! cells.! These! results! showed! that!
cells!at!these!densities!stopped!growing.!Based!on!these!results,!we!determined!
the!optimal!cell!seeding!density!of!YCC1!to!be!1000!cells.!We!applied!the!same!
screening! to! sixteen!other! cell! lines! including!MCF7.! Table! 3.2! summarizes! the!



















B.! Proliferation! rates! of! gastric! cancer! cell! lines! at! their! optimal! density! at! the!












Cell(lines( Cell(numbers( Cell(lines( Cell(numbers(
IM95! 5000! YCC16! 1000!
YCC6! 5000! Hs746T! 1000!
AGS! 1000! Ist1! 5000!
AZ521! 3000! MKN7! 3000!
MCF7! 3000! YCC7! 5000!
YCC10! 5000! TMK1! 1000!
YCC3! 2000! YCC1! 5000!
MKN74! 3000! MKN1! 1000!
YCC11! 1000! ! !
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proliferation! screening! with! DZNep! treatment.! We! seeded! 16! GC! cell! lines! in!
their!optimal!cell!density!according!to!Table!3.2.!We!measured!for!proliferation!
activity!in!terms!of!absorbance!at!490nm!the!next!day,!T0,!before!drug!treatment!
started.!We! treated! the!GC! cell! lines!with! increasing! concentrations! of! DZNep!
from!0.5uM!to!100uM,!and!assessed!their!growth!rates!at!72!hours.!MCF7!cells,!
for!which!DZNep!responses!have!been!previously!characterized!in!earlier!report!
(203)! and! also! NCI60! cell! screen!
(http://www.dtp.nci.nih.gov/announcements/chg_to_screen.html),! were!
included! as! a! positive! control.! The! growth! curves! of! each! cell! line! at! different!
DZNep! concentrations! were! shown! in! Figure! 3.6.! For! each! cell! line,! we!
determined! the!GI50!values!by!plotting!GI50!curves!using! formula:! [(TdET0)/(CE
T0)]! x! 100! =! 50]! using! absorbance! measurements! of! [time! zero,! (T0);! control!
growth,!(C);!and!test!growth!in!the!presence!of!drug!at!the!seven!concentration!
levels! (Td)]! as! shown! in! Figure! 3.7! with! IM95! cells! as! an! example.! GI50! value!
referred!to!the!drug!concentration!required!to!cause!50%!growth!inhibition.!!
!!In! contrast! to! the! seemingly! homogeneous! effects! on! EZH2! and! H3K327me3!
depletion! (Figure! 3.4),! we! found! that! DZNep! caused! very! distinct! growth!
responses! amongst! the!GC! cells! (Figure!3.8).! Specifically,! IM95,! YCC6,!AGS!and!
AZ521!cells!demonstrated!the!highest!sensitivity!to!DZNep!(GI50=0.3uM!to!2uM)!
while! cell! growth! in! other! lines! such! as! TMK1,! YCC7,! Ist1! and!MKN7! was! not!






difference!between! the!most!DZNep! sensitive!and! resistant! lines,!with!a!mean!
GI50!value!of!15.8uM.!These!results!suggest!that!other!factors,!either!parallel!or!
















































Figure( 3.6.( Growth( curves( of( cancer( cell( lines(with( various( concentrations( of(
DZNep(after(72(hours.(
Cells!were!treated!with!DZNep!in!multiple!concentrations!from!0.5uM!to!100uM!














IM95! cells!were! treated!with!DZNep! in!multiple! concentrations! from!0.5uM! to!
100uM!for!72!hours.!GI50!value!is!calculated!by![(TdET0)/(CET0)]!x!100!=!50]!using!


















with! increasing! DZNep! concentrations! (0.5uM! E! 100uM)! for! 72! hours! to!
determine!individual!cell!line!growth!inhibitory!GI50!values.!MCF7!was!included!
as! a! known! DZNepEsensitive! cell! line! (positive! control,! GI50! value! for! MCF7!
shown! in! blue).! YEaxis:! Mean! GI50! values! (|log10GI50|,! M);! XEaxis:! standard!
deviation!of!GI50s!across!cell! lines!compared!with!the!mean!GI50!set!as!0;!blue!
and! red! color! bars:! DZNep! sensitive! and! resistant! cell! lines.! At! least! three!
independent!experiments!were!conducted!per!line.!The!MCF7!GI50!value!is!very!
similar! to! concentrations! obtained! in! earlier! studies!












!!To!establish!a! standardized!experimental! concentration!of!DZNep,!we! treated!
four!sensitive!(IM95,!YCC6,!AZ521!and!AGS)!and!four!resistant!lines!(TMK1,!YCC7,!
Ist1!and!MKN7)!with!5uM!DZNep!and!determined!their!growth!rates!after!24,!48!
and! 72! hours! treatment.! 5uM! was! chosen! as! a! working! concentration! based!
upon!previous!reports!(189,!202)!.!It! is!also!a!concentration!which!distinguishes!
the! four! most! sensitive! cells! and! positive! control,! MCF7! from! intermediate!
responsive! and! also! other! resistant! cells! (Figure! 3.8).! We! compared! the!
proliferation!of!DZNepEtreated!cells!with!that!of!DMSO!(control)Etreated!cells!of!
each! cell! line! at! each! time! point! (Figure! 3.8).! Similar! to! the! GI50! analysis,!
sensitive! GC! lines! exhibited! a! significant! growth! inhibition! at! both! 48! and! 72!
hours! DZNep! treatment! compared! to! DMSO! control! cells! while! resistant! lines!
were!unaffected!(p<0.05)!(Figure!3.9).!!Because!inhibition!of!cell!proliferation!can!
be!due!to!a!variety!of!molecular!mechanisms,! including!cell!cycle!perturbation,!


















48! and! 72! hr! time! points.! %! cell! survival! is! represented! by! comparing! the!

























staining!buffer! to!degrade! the! released!RNA! in!each! sample.!DNA!content!was!
then! captured! by! flow! cytometry! and! analysed! by! ModFit! LT! software.! DNA!
duplexes,! which! caused! false! positive! and! background! to! the! analysis,! were!
gated!out!by!performing!doublet!discrimination!analysis!in!machine!setting!with!
yEaxis!set!as!AUXEAUX!(auxiliary)!and!xEaxis!set!as!FL3!parameter.!The!y/x!ratio!of!
singlet! cells! is! equal! one! while! the! representative! signal! dots! on! Figure! 3.9!
aligned!along!a!visual!diagonal!line:!y=x.!On!the!other!hand,!the!y/x!ratio!of!the!
doublet!cells!is!½!or!<!1!and!the!representation!signal!dots!align!below!y=x.!Using!












stain.! This! cell! population! appears! to! the! left! of! the! G1! peak! (SubEG1).! This!
indicates!IM95!cells!undergo!apoptosis!upon!DZNep!exposure.!!
!!To!further!confirm!apoptosis!in!IM95!cells,!we!have!performed!Annexin!V/7AAD!
assay.! Classic! features! of! apoptosis! start! with! the! translocation! of!
phosphatidylserine!(PS)!from!cytoplasmic!leaflet!of!the!plasma!membrane!to!the!
cell! surface!and! then! followed!by! the! loss!of!membrane! integrity.!Thus,! in! late!
apoptosis,! PS! is! exposed! for! the! binding! of! Annexin! V! and! nucleic! acid! is!
subjected!to!7AAD!binding,!which!is!a!DNA!dye.!There!was!an!increase!in!double!
positive! cells! by! 39%! (from! 7%! to! 46%),! in! IM95! cells! after! DZNep! treatment!
(Figure!3.11,!Top!Left,!Dotplot).!!
!!In! contrast,! DZNepEsensitive!AGS! and!AZ521! cells! displayed!mild! apoptosis! as!
illustrated!by! the! increase!of! subEG1!population!by!5.1%! (from!6.4%! to!11.5%)!
and! 6.6%! (from! 6.8%! to! 13.4%)! respectively! and! additionally! exhibited! a! G1!
population! increase! by! 6.9%! (from! 60%! to! 66.9%)! and! 11.6%! (from! 58.8%! to!
70.4%)! respectively!after!DZNep!treatment! (Figure!3.11!Top!right,!Bottom!Left;!
DNA!histogram).!As!more!cells!stay!in!G1!stage!in!their!life!cycle,!fewer!cells!will!
go! into! S! phrase,! DNA! synthesis! stage,! leading! to! cell! growth! inhibition.!
Morphologically,! AGS! and! AZ521! became! enlarged! and! flat,! and! exhibited!







Cell!pictures!and!Figure!3.11B).!These! indicated! the! induction!of! senescence! in!
these!cell!lines!by!DZNep!(210).!No!significant!changes!in!DNA!content,!apoptosis!
and! senescence! characteristics! were! observed! in! resistant! TMK1! cells! after!
DZNep!treatment!(Figure!3.11,!Bottom!Right).!!
!!Taken! collectively,! our! results! demonstrated! that! DZNep! induces! distinct!
cellular! responses! in! sensitive! GC! cells.! These! suggest! DZNep! is! likely! to! elicit!



























































A.! DZNep! induces! an! increase! in! G1! population,! apoptosis! and! senescence! in!
sensitive! GC! cells.! After! 48! hours! of! treatment,! sensitive! GC! lines! (IM95,! AGS,!
AZ521)! were! compared! against! a! representative! resistant! line! (TMK1,! bottom!
right).!DNA!content!analysis:!DZNep!and!control! treated!cells!were!analyzed!by!
flow! cytometry! (representative! red! histograms! under! cell! line! names,! all!
histograms!are!in!same!scale).!Black!arrows!indicate!changes!in!DNA!content.!Cell!




46%)! is! observed! after! DZNep! treatment! (red! arrow).! Senescence! analysis:!
Morphology!changes!of!DZNep!and!controlEtreated!cells!were!monitored!under!
white!light!microscopy.!Levels!of!cell!senescence!were!determined!in!DZNep!and!
controlEtreated! cells! using! senescence! associated! βEgalactosidase! staining! (SAE
βGal,!photomicrographs).!DZNepEsensitive!lines!AGS!and!AZ521!exhibit!enlarged!
and! flattened! cellular! morphologies! and! an! increase! in! senescent! populations!
following! treatment! (black! arrows! in! photomicrographs).! No! senescent!
phenotypes! are! seen! in!DZNepEresistant! TMK1! cells! (bottom! right).! Photos! are!
shown!at!20x!magnification.!Data!is!based!on!three!independent!experiments.!
C.! Quantification! of! cell! senescence.! Bar! charts! show! the! average! %! SAEβGal!
stained!cells!of!AGS!and!AZ521!cells!in!control!(DMSO)!and!DZNepEtreated!cells.!





















lines.! Firstly,! the! molecular! determinants! regulating! DZNep! cellular! response!
could!lie!downstream!of!EZH2!but!may!only!be!selectively!activated!in!sensitive!







!!To! determine! if! the! cellular! responses! induced! by! DZNep! on! GC! cells! are!
mediated!through!EZH2,!we!silenced!EZH2!expression!in!the!GC!cell!line.!In!these!
experiments,!we!used!a!validated!EZH2!siRNA!from!previous!report! in!order! to!
minimize! the! possible! offEtarget! effect;! meanwhile,! we! have! included! a!
scrambled!siRNA!as!a!control!for!the!same!purpose.!The!aforementioned!report!
showed! the! EZH2! siRNA! sequence! was! sensitive! and! specific! to! EZH2! by!









always! observed! a! relatively! low! knockdown! efficiency! in! IM95! cell! lines! likely!
due!to! its!clumpy!nature.!We!then!investigated!what!the!phenotypic!effects!on!
GC! cells! are! induced!after! the! siRNAEmediated!depletion!by!performing! a!DNA!
content!analysis.!We!compared!with!the!results!of!EZH2!siRNA!knockdown!cells!
with! scrambleEsiRNA! treated! cells.! ! Similar! to! DZNep! treatment,! EZH2! gene!
silencing!caused!a!significant!increase!in!the!population!of!subEG1!cells!by!20%,!
in!IM95!cells,!increase!of!G1!population!by!9%!in!AGS!cells!and!8%!by!AZ521!cells!
together! with! mild! induction! of! subEG1! population.! No! significant! DNA!
alterations! in! TMK1! cells! was! observed! although! 60%! of! EZH2! protein! was!
depleted!similar!as!in!other!cell!lines!(Figure!3.12B).!!!
!!These!results!suggested!that! the!cellular!effects! induced!by!DZNep! in!GC!cells!
are! likely! to! involve! EZH2! and! are! not! due! to! an! offEtarget! effect.! Moreover,!






























































































































B.!Cell! cycle! responses!of! scrambled!and!EZH2Esilenced!cells! after! transfection.!
DNA!content!of!Scr!or!siEZ!treated!cells!were!determined!by!PI!staining!and!flow!
cytometry.! All! histograms! are! plotted! in! the! same! scale.! Black! arrows! indicate!
the! DNA! content! changes! induced! by! EZH2! silencing.! Percentages! of! cells! in!
subG1!(<G1)!and!G1!population!are!shown!in!the!right!corner!of!each!histogram.!
EZH2!knockdown!caused!significant!induction!of!sub!G1!population!in!IM95!cells!

























in! several! cancers! including! GC! (57,! 58).! ! In! normal! cells,! p53! proteins! are!
maintained! at! low! levels! by! MDM2Emediated! ubiquitination! (211).! During!








GC! cell! lines! by! sequencing! all! eleven! p53! exons! in! each! cell! line! by! Sanger!
Sequencing.!p53+genomic!status!was!summarized!in!Table!4.1.!9/16!(56%)!of!the!
GC!lines!were!p53Emutated,!a!frequency!comparable!to!the!published!literature!
(57).!We!observed!a!p53!deletion! in! Ist1!and!two!hot!spot!mutations! in!the!GC!








to!DNA!and! function! as! a! transcription! factor.!All! of! the!mutants!we!observed!
were!reported!to!be!inactivating!(214).!Importantly,!we!found!that!6/7!(86%)!of!
the!DZNepEsensitive!GC!cell!lines!harbored!wild!type!p53+genes,!while!8/9!(88%)!
















p53! exons! (1E11)! were! sequencing! in! 16! cell! lines.! Cell! lines! in! blue:! DZNep!














A.! p53+ genomic! status! in! DZNepEsensitive! (blue! columns)! and! resistant! (red!


















4.1.2.( DZNep( Treatment( Causes( p53( Protein( Accumulation( with( no(
Transcriptional(Induction(
!!To!investigate!if!the!diverse!cellular!responses!induced!by!DZNep!might!be!due!
to! activation! of! wildEtype! p53,! we! analyzed! p53! protein! expression! in! DZNep!
sensitive!and!resistant!GC!lines,!and!also!MCF7!cells,!which!are!DZNep!sensitive!
and! also! p53+ wild! type! (202).! Loewer! et+ al.! has! demonstrated! p53! protein!
expression!is!dynamic!(33).!To!elaborate,!under!both!normal!condition!and!also!
stress! condition,! p53! expression! is! in! repetitive! cycle! of! increasing! and!
decreasing,! despite! the! varying! duration! and! amplitude.! Thus,! it! is! very!





in! p53Emutated! TMK1! cells,! which! already! express! high! levels! of! mutant! p53!
protein!(Figure!4.2A).!!
!!p53!protein!accumulation!could!be!primarily!due!to!!transcriptional!induction!or!













Figure( 4.2.( DZNep( causes( p53( accumulation( without( transcriptional(
upregulation(of(p53(mRNA.(((
A.!DZNep! causes! p53! protein! accumulation! in! sensitive! cell! lines.! Cells! treated!
with!DZNep!(+)!or!DMSO!control!(E)!after!6!hours!were!analyzed!for!p53!protein!
expression.! βEactin! was! used! as! a! loading! control.! DZNep! causes! p53! protein!
accumulation! in!p53EwildEtype! sensitive! GC! cells! and! also!p53! wildEtype!MCF7!
cells,!but!not!in!p53Emutated!TMK1!cells!(rightmost!lanes).!!
B.! DZNep! does! not! cause! p53! transcriptional! upregulation.! Quantitative! PCR!
(qPCR)!analysis!of!p53!gene!expression!in!cells!treated!with!DZNep!(+)!or!DMSO!








4.1.3.(DZNep( Treatment( Causes(Activation( of( Canonical( p53( pathways( in( p53(
WildSType(but(Not(Mutant(Cells!
!!Although! DZNep! caused! p53! protein! stabilization,! p53! levels! are! possibly!
uncoupled!from!its!transcriptional!activity!as!suggested!by!Loewer!A.!et+al.!(33).!
To! assess! the! functionality! of! this! p53! accumulation,! we! then! investigated! if!
DZNep! treatment!might! also! cause! the! transcriptional! activation! of! p53! target!
genes!specifically!related!to!apoptosis,!cell!cycle! inhibition!and!senescence.!We!
selected!the!following!canonical!p53!target!genes!for!analysis:!FAS!and!DR5!are!
transcriptional! targets! of! p53! encoding! death! receptors! (36,! 217,! 218)! whose!
upregulation! in! p53! wildEtype! cancer! cells! by! drug! or! DNA! damage! can! cause!
apoptosis! (218E222).!p21+ and!GADD45α! are! p53! target! genes! involved! in! p53E
mediated! growth! inhibition! and! senescence! (223E225).! We! also! included! the!
MDM2! E3! ubiquitin! ligase,! as! a! general! p53! activation! marker,! as! MDM2! is!
upregulated! in! both! growth! inhibited! and! also! in! apoptotic! cells! upon! p53!
activation.! We! performed! quantitative! PCR! for! samples! after! 6! hours! DZNep!
treatment! (Figure! 4.3,! Left)! and! also! western! blot! for! samples! harvested! at! 6!
hours!of!DZNep!or!DMSO!treatment! (Figure!4.3,!Right).!βEactin,!43kDa!showed!
that!the!loading!!of!whole!protein!lysates!was!equal.!!
!!After! 6! hours! DZNep! treatment,!MDM2,! DR5! and! FAS!mRNA! transcripts! and!
proteins!were! consistently! induced! (up! to! sixEfold! at! the!mRNA! level)! in! IM95!







effective! EZH2! inhibitor! (Figure! 4.3A,! Right).! There! are! specific! band! at! 53kDa!
showing! p53! protein! is! stabilized! at! 6! hours.! The! p53! expression! level! was!
correlated! with! MDM2! protein! expressions,! which! are! around! 90kDa.! MDM2!
protein!was!induced!at!6!hours!by!the!stabilized!p53!proteins!(Figure!4.3A,!Right).!
DR5! and! FAS! proteins! were! also! induced! in! IM95! cells! after! 6! hours! DZNep!
exposure.!!
!!Moreover,! AGS! and! AZ521,! which! exhibited! growth! inhibition! after! DZNep!
treatment,!also!demonstrated!p53!protein!upregulation!and!MDM2!upregulation!
(up! to! threeEfold)! at!mRNA!and!protein! levels! after! 6! hours!DZNep! treatment.!
Conversely,!there!was!an!upregulation!of!the!two!other!growth!inhibition!related!
markers,! p21! and/! or!GADD45α! at! both!mRNA! and! protein! levels! (Figure! 4.3B!
and!C)!as!illustrated!by!the!specific!p21!band!at!p21!kDa!and!GADD45α!band!at!
18kDa!similar!to!the!predicted!molecular!weights.!!
!!In!contrast! to! these!p53!wildEtype!cells,!we!did!not!observe!MDM2! induction,!
nor!activation!of!any!of!the!other!p53!target!genes!including!FAS,!DR5,!p21!and!
GADD45α! at! mRNA! levels! (Figure! 4.3D,! Left),! in! p53Emutated! TMK1! cells.! At!
protein! level,! EZH2! protein!was! depleted,! however,! there!was! no! p53! protein!
accumulation! and!MDM2! protein! induction! (Figure! 4.3D,! Right).! These! results!



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































p<0.05! relative! to!DMSO!controlEtreated! cells.! Three! independent! experiments!
were!conducted! for!each! line.! (right)!Protein!measurements.!Cells! treated!with!



























p53! targets! observed! in! the!DZNep! sensitive! lines! are!mediated! through! EZH2!
and! not! an! offEtarget! effect,!we! performed! siRNAEmediated! EZH2! depletion! in!
the!cell! lines!and!measured!EZH2!and!p53!protein!expression.!Similar!to!DZNep!
treatment,!EZH2!siRNA!caused!EZH2!depletion!and!also!p53!protein!stabilization!
in! the!absence!of!p53!mRNA! transcript!upregulation! in!p53!wildEtype! sensitive!
cells! (Figure!4.4,! Left).!SiRNAEmediated!EZH2!depletion!also!caused!an! increase!
of!MDM2!transcripts!in!all!sensitive!cell!lines!(up!to!3.5!fold)!(Figure!4.4A,!B!and!
C).! Consistent! with! the! DZNep! results,! EZH2! depletion! did! not! trigger! p53!
stabilization! nor!MDM2! upregulation! in! DZNep! resistant! TMK1! cells! which! are!
p53!mutated!despite!of!the!similar!knockdown!efficiency!of!EZH2!with!other!cell!












































































































































































(IM95,! AGS,! AZ521)! and! resistant! (TMK1)! cells.! Cells! were! harvested! after! 48!
hours! of! knockdown! by! validated! EZH2! siRNA! sequences! or! control! scrambled!
siRNAs.! (Left)! Protein!measurements.! p53! protein! expression! was! analyzed! by!
immunoblotting.!βEactin!expression!was!used!as!a!loading!control.!(Right)!mRNA!
measurements.! qPCR! mRNA! measurements! were! normalized! against! a! TBP!
control.!mRNA!expression!of!genes!in!EZH2EsiRNA!treated!samples!(grey!column)!
were!compared!to!scrambled!siRNA!treated!controls!(white!column).!*!indicates!
p<0.05! relative! to! scrambled! siRNAEtreated! control! cells.! Three! independent!
experiments!were!conducted!for!each!line.!EZH2!depletion!by!siEZH2!causes!p53!









































a! proteasome! inhibitor! compound!which! blocks! the! proteolytic! activity! of! 26S!
proteasome! (226).! As! shown! in! Figure! 4.5B,! MG132! treatment! preserved!
ubiquitin!conjugates!of!p53!from!degradation,!with!more!apparent!conjugates!in!







p53! by! reducing! proteasomal! degradation.! Consistently,! DZNep! treatment!











A.! ! Cells! treated! with! DZNep! (+)! or! DMSO! (E)! were! analyzed! for! levels! of!
ubiquinated!p53.!βEactin!was!used!as!a!loading!control.!After!six!hours!of!DZNep!
exposure,!decrease!of!ubiquitination!of!p53!coupled!with!p53!accumation!were!























silencing!using! validated!EZH2! siRNA! instead!of!DZNep!by!western!blotting.! To!
visualize! the! ubiquitin! levels,! we! incubated! the! scrambled/antiEEZH2! siRNAE
treated! cells! with! 10uM! MG132! for! 3! hours! before! sample! harvesting! using!
ubiquitinEpreserved!buffer.!MG132!stabilized!all!the!cellular!ubiquitinEconjugated!
p53!protein!resulting!in!equal!level!of!p53!while!EZH2!siRNA!we!used!significantly!
inhibited! EZH2! proteins! in! all! cell! lines.! However,! EZH2! silencing! reduced! the!
ubiquitination!level!in!p53!wildEtype!cells!only!but!not!in!TMK1!cells!(Figure!4.6B).!








































!!MDM2! is! the! key! regulator! of! p53! level! by! ubiquitination! (28).! Upon! EZH2!
depleted! by! either! DZNep! or! siRNA,!MDM2! is! transcriptionally! induced.! These!
rules! out! the! possibility! of! DZNep! effect! on! MDM2! inhibition.! ARF! binds! to!
MDM2!and!promote! rapid!MDM2!degradation! (227).! Recently,! EZH2!has! been!
found!to!bind!to!and!suppress!transcription!of!INK4AEARF!locus!(228).!It!may!be!
possible! that! EZH2! silencing! by! DZNep!may! increase! INK4AEARF! gene! product,!
p14!and!p16,!where!p14!may!then!degrade!MDM2!leading!to!p53!stabilization.!
To!explore!this!possibility,!we!measured!the!protein!expressions!of!p14!and!p16!
after!DZNep!treatment! in!two!sensitive!representative!cell! lines,! IM95!and!AGS!








experiment! revealed! that! p14! mRNA! was! not! upregulated! by! DZNep! after! 6!













A. Cells! were! treated! with! DZNep,! harvested! at! various! time! points,! and!
examined!for!expression!of!p16!and!p14!by!immunoblotting.!βEactin!expression!
was!used!as! a! loading! control.! Commercial!HeLa!protein! lysate!as!p16!positive!



















results! in! p53! stabilization.!Most! of! the! classic! p53! stabilizing! drugs! such! as! 5E
fluorouracil! (5FU)!work! through!by! this! pathway! (231).! To! investigate!whether!
DZNepEreduced!ubiquitination!is!dependent!on!ATM/p53ser15/MDM2!pathway,!
we!examined!the! levels!of!specific!pathway!activation!markers,!phosphorylated!




!!Our! antiEγH2AX! antibody! detected! single! dominant! specific! band! at! 15kDa!
similar! to! the! predicted!molecular! weight! in! our! 5FU! treated! cells! as! positive!
control.!Despite!the!efficacy!of!the!antibody,!there!was!no!detectable!increase!of!









!!We! further! investigated! the! level! of! phosphorylation!of! ser15! residue!on!p53!
using! antiEphoEp53! (ser15)! antibody! at! early! time! points.! By! comparing! the!































does! not! induce! significant! phosphorylated! ser15! on! p53! before! p53! protein!














!!We! further! sought! to! identify! if! DZNep! interrupts! MDM2Ep53! interaction! by!
immunoprecipitation! assays! (Figure! 4.9).!We! pulled! down! p53! and! its! binding!












90KDa! for! MDM2! proteins.! No! nonEspecific! bands! were! detected! in! IgGE
partcipitated! lysates! at! these! positions.! More! p53! precipitated! after! DZNep!
treatment!as!p53!protein!was!accumulated.!To!our!surprise,!there!was!also!more!
MDM2!bound!to!p53!upon!exposure!to!DZNep!in!both!cell!lines.!!
!!Two! possibilities! could! contribute! to! the! increase! of! MDM2! binding.! First,!
DZNep!might! still! perturb!MDM2Ep53! interaction! but! the! experimental! results!
might!be!influenced!by!the!proportional!increase!of!binding!by!the!accumulated!










!!Taking! collectively! from! these! results,! our! analysis! suggests! that! activation! of!










subjected! to! immunoprecipitation! with! control! IgG! and! antiEp53! antibodies.!
Inputs!were!total!lysates.!The!immunoprecipitates!and!inputs!were!then!blotted!























!!This! analysis! suggests! ribosomal! proteins,! RPL5,! RPL23! or! RPL26! RNA!
expressions! were! not! increased! by! DZNep! treatment.! However,! we! could! not!
exclude!their!possible!involvements!in!DZNep!effect.!Further!experiments!could!











Quantitative! PCR! analysis! of! RPL5,! RPL23! and! RPL26! gene! expression! in! cells!
treated!with!DZNep!or!DMSO!control!after!6!hours.!TBP!expression!was!used!as!a!
normalization! control.! DZNep! effects! on! each! transcript! were! investigated! by!
comparing! the! transcript! level! of! DZNepEtreated! cells! to! DMSOEtreated! cells.!





















reduces! the! ubiquitination! of! p53! without! affecting! the! primary! interaction!
between! MDM2! and! p53! (45,! 233,! 234).! USP7! was! initially! identified! as! first!
deubiquitinase!for!p53!before!the!discovery!of!deubiquitinase!function!of!USP10!
(41).! In! the! study! by! Li! M! et+ al,! overexpression! of! HAUSP! leads! to! p53!
stabilization.!But!later!on,!two!followingEup!papers!reported!the!dynamic!role!of!
USP7! where! partial! reduction! of! USP7! level! leads! to! p53! level! reduction! but!
complete! USP7! ablation! leads! to! p53! stabilization! via! Mdm2.! Subsequent!
crystallography!studies!showed!USP7!physically!binds!to!both!MDM2!and!p53!in!
a! mutually! exclusive! manner! in! which! USP7! has! a! higher! affinity! to! bind! to!
MDM2.! Under! normal! conditions,! USP7! deubiquitinates! MDM2! and! MDMX!
resulting! in! p53! destabilization.! However,! upon! DNA! damage,! MDM2! is!
dissociated! from! p53! due! to! phosphorylation! by! ATM! pathway! leads! to! p53!
upregulation! (235).! Further! investigations! are! needed! to! understand! how! the!
interactions!among!p53,!USP7!and!MDM2!are!dynamically!regulated!upon!DNA!
damage!and!whether!USP7!exclusively!dedicated!to!the!p53EMDM2!pathway!(41).!!!!!
!!We! then! investigated! if! any! of! these! nonEclassic! MDM2! regulators! might!
contribute! to! our! observed! p53! stabilization! after! DZNep! treatment.! We!
















but! in! just! two!out!of! the!three! lines! (AZ521!and!AGS).!Due!to! this!preliminary!











Figure( 4.11.( DZNep( effects( on( NUMB,( USP10,( TSPYL5( and( USP7( gene(
expressions.((
Quantitative!PCR!was!normalized!against!TBP! controls.!Cells!were! treated!with!


















!!We! further! characterized! DZNep! effects! on! NUMB,! USP10! and! TSPYL5!
expressions! after! EZH2! depletion.! Using! validated! antiEEZH2! siRNA,! EZH2!
silencing!resulted!in!significant!induction!of!NUMB!transcripts!(up!to!>6Efold)!and!
USP10!transcripts!(up!to!>3Efold)!while!there!were!no!transcriptional!induction!of!




!!Our! results! suggest!DZNep! treatment! induced!NUMB,!USP10! in!p53!wildEtype!
cell! lines! at! transcriptional! levels! associated! with! EZH2! silencing.! DZNep!
treatment!did!not!cause!universal!reduction!of!USP7,!however,!TYPSL5!transcript!













siRNA! for!48!hours!and!mRNA!expression! levels!were!normalized! to! scrambled!
treated! control.! *! indicates! genes! that! are! significantly! upregulated! (p<0.05)!
relative! to! scrambled! treated! control! for! each! line.! Arrows! at! the! corner!
represent! the! expected! result! for! each! gene! while! ↑! means! expected!
upregulation,!↓means!expected!downregulation.!!EZH2!silencing!induced!NUMB!
and!USP10!mRNA!in!sensitive!cells!only!while!the!silencing!did!not!reduce!TSPYL5!














!!We! further! examined! if! there! is! protein! level! change! of!USP10! and!NUMB! in!
DZNep! sensitive,! p53! wildEtype! GC! lines! (IM95,! AZ521,! AGS)! and! the! resistant!
mutant!TMK1!line!at!multiple!time!points!up!to!6!hours!of!DZNep!treatment!by!
western!blotting.!We!observed!dominant!bands!at!100kDa!and!75kDa!by!USP10!




no! similar! induction! was! observed! in! the! control! TMK1! cells! (Figure! 4.12! and!
4.13).! Additionally,! using! the! same! protein! lysates! in! Figure! 4.8,! p53!were! not!
stabilized! until! 6! hours.! This! data! suggest! that! it! is! less! likely! for! NUMB! and!




NUMB! shRNA! sequence! (234)! and! siRNA! respectively.! ! In! figure! 4.14,! we!
demonstrated!that!DZNepEinduced!p53!stabilization!was!not!affected!by!NUMB!
expressions.! Interestingly,! USP10! knockdown! reduced! wildtype! p53! protein!
expressions! (Figure! 4.15).! This! result! further! supported! a! regulatory! role! of!






expressions! of!mutant! p53.! It! is! likely! due! to! the! biology! that! the!mutant! p53!
proteins! cannot! be! regulated! by! ubiquitination.! We,! then,! found! USP10!
depletion! significantly! attenuated! wild! type! p53! stabilization! upon! DZNep!
treatment!compared!with! the!parental! IM95!cells! (Figure!4.15A).!The!mild!p53!
stabilization! could! be! caused! by! the! slight! induction! of! USP10! in! the! USP10E
depleted!cells.!In!addition,!it!is!also!likely!that!USP10!works!together!with!other!
players! resulting! in! p53! stabilization! upon! DZNep! treatment.! Our! chromatin!
immunoprecipitation! assays! showed! an! EZH2! binding! enrichment! upstream! of!
USP10!promoter!and!the!binding!was!reduced!by!DZNep!treatment.!Due!to!the!
architecture!of!USP10!promoter! region!with! repeated!elements! across! 3000bp!
upstream! and! downstream,! we! are! encountering! technical! difficulty! to! design!
primers!for!examining!H3K27me3!enrichment!at!USP10!promoter!region.!Despite!
of! lacking! that! piece! of! data,! our! results! suggest! that! DZNepEinduced! p53!
stabilization!may! not! be!mediated! through! the! classical! ATM/p53ser15/MDM2!
pathway,! but! via! an! alternative! pathway! associated! with! USP10.! We!
demonstrated! DZNep! treatment! reduced! EZH2! binding! on! USP10! promoter!
region,!and!this!may!highly!likely!associated!with!upregulation!of!USP10!protein!














Western! blots! of! USP10! and! NUMB! in! sensitive! cells! (IM95,! AGS,! AZ521)! and!
resistant! TMK1! cells! after! DZNep! treatment! at! various! time! points.! Elevated!
levels!of!USP10!and!NUMB!protein!expressions!are!observed!at!early!time!points!
in! sensitive! cells! but! not! TMK1! cells.! βEactin! was! used! as! a! loading! control.!





































Figure( 4.15.( USP10( and( p53( protein( expression( in( parental( and( USP10(
knockdown(cells(after(DZNep(treatment.(
A!sensitive! representative! cell! line,! IM95! (A)! and! resistant!TMK1!cells! (B)!were!
treated!with!scrambled!(Scr)!or!USP10!siRNAs!(+)!for!72!hours.!Cells!were!treated!
with! DZNep! for! 6! hours.! EZH2,! USP10! and! p53! protein! expressions! were!
determined!by!immunoblotting.!βEactin!expression!was!used!as!a!loading!control.!
Numbers! below! each! blot! indicate! the! intensity! normalized! to! βEactin.! USP10!


















ChIP!assays!were!performed!using!EZH2!antibody.! The!enrichments!of! EZH2! in!
USP10!promoter! region!and!control! region!were!examined!by!quantitative!PCR!






























((To!provide! functional! evidence!of! the!p53!pathway! in!DZNepEinduced! cellular!
phenotypes,!we!!used!retroviral!transduction!to!generate!IM95,!AGS,!AZ521!cells!
where!p53!levels!were!stably!reduced!using!validated!p53!shRNAs!(236)!(Figure!
5.1).! Specifically,! our! quantitative! PCR! showed! 50%!of! p53!mRNA! reduction! in!
IM95!cells!compared!with!the!parental!cells!with!an!empty!vector!transduced.!In!
AGS!and!AZ521,! there!was!drastic! reduction!of!p53!mRNA! to! less! than!20%!of!
that!of!parental!cells!(Figure!5.1A).!The!difference!in!transduction!efficacy!could!
be! explained! by! the! different! natures! of! the! cells.! IM95! cells! grow! tightly!
together!to!form!clumps!while!AGS!and!AZ521!grow!as!a!monoElayer!on!culture!
plates.! The! clumpy! nature! of! IM95! cells! may! make! the! access! of! viruses! less!



















cells! were! determined! by! immunblotting.! βEactin! expression! was! used! as! a!
loading! control.! The!p53! shRNA! sequence!depleted!p53!expression! in! all! three!
cell!lines.!
!
!B.! Protein! expression! of! parental! and! stable! knockdown! cells.! Cells! were!
transduced! with! retroviruses! containing! either! empty! vector! (EV)! or! validated!

















in! both! parental! cell! lines! and! p53Eknockdown! cell! lines! by! western! blotting.!
DZNep! treatment! depleted! EZH2! in! both! parental! and! knockdown! cells!
regardless!of!p53!expressions,!similar!to!the!original!results!(Figure!3.4).!DZNep!










immunoblotting.! βEactin! expression! was! used! as! a! loading! control.! The! p53!














!!We! then! examined! the! DZNepEinduced! phenotypic! and! molecular! effects! in!
p53Eknockdown!cells! in!which! the!DZNep! induced!p53! stabilization!was! largely!
reduced.!Importantly,!we!found!that!p53Eknockdown!cells!were!now!significantly!
more!resistant!to!DZNep!in!terms!of!their!cellular!phenotypes!while!parental!cell!
lines! demonstrated! similar! DZNep! effects! as! our! original! results! in! nonE
engineered!cells.!Specifically,!80%!of!p53Eknockdown!IM95!cells! remained!alive!
after!DZNep!treatment,!compared!to!45%!of!parental!IM95!cells!(p<0.05)!(Figure!
5.3A! (Left)).! At! the! molecular! level,! DZNepEinduced! p53! downstream! targets!
(MDM2,!DR5!and!FAS)!were!also!no!longer!significantly!upregulated!in!the!p53E
knockdown! IM95s! cells! (p<0.05).! Specifically,! there! was! around! threeEfold! or!
above!transcriptional! induction!of!MDM2,!DR5!and!FAS!after!DZNep!treatment,!
however,! the! fold! change! of! induction! dropped! to! 1.5! fold! or! less! in! p53E
knockdown! cells! (Figure! 5.3A! (Right)).! Similarly,! DZNep! caused! G1! population!
increase! in! parental! AGS! and!AZ521! cells,! but! p53Eknockdown!AGS! and!AZ521!
cells! displayed! significantly! reduced! levels! of! G1! population! induction! (Figure!
5.3B!and!5.3C! (Left)).! !Consistently,!DZNep!caused!2Efold!or!above! induction!of!
p53!downstream!target!genes!(MDM2,!GADD45α!and!p21!or!GDF12)!in!AGS!and!
































A.! p53! silencing! in! DZNep! sensitive! lines! (IM95,! AGS,! AZ521).! Cells! were!
transduced! with! retroviruses! containing! either! empty! vector! (EV)! or! validated!




DZNep! treatment.! Percentages! of! surviving! and! apoptotic! cells,! determined!by!
Annexin!V/7AAD!staining!are!shown!in!each!quadrant.!Surviving!cell!populations!
(low!Annexin!V!and!7AAD)!are!shown!by!the!black!arrows.!In!empty!vector!(EV)!
cells,! DZNep!decreases! the! surviving! population! by! 49%! (91%! to! 42%).! In! p53E
silenced!cells!(shp53),!DZNep!decreases!the!surviving!population!by!21%!(87%!to!
66%).!The!bar!chart!confirms!a!significant!difference!in!surviving!IM95!cells!after!
DZNep! treatment! between! EV! and! shp53! (Sh)! cells.! (Bar! charts! on! right)!
Transcriptional! induction! of! p53! target! genes! involved! in! apoptosis.! Gene!









are! indicated! at! the! right! corner! of! each! histogram.! Black! arrows! indicate!
changes! in!DNA!content! induced!by!DZNep! in!EV!cells.! Similar! changes!are!not!
observed! in! shp53! cells.! (Bar! charts! on! right)! Transcriptional! induction! of! p53!
target! genes! involved! in! cell! cycle! processes.! Gene! expression! increases! are!
observed!in!EVEAGS!and!EVEAZ521!cells,!but!there!is!significantly!less!induction!in!



















5.2.( Exploration( of( Possible( effects( of( High( EZH2( Levels( on( p53( Activity( in(
Cancers!!
!!Finally,!the!discovery!of!pharmacological!EZH2!depletion!by!DZNep,!resulting!in!










p53! activity! scores! across! a! cohort! of! 132! primary!GC! samples!where! the! p53!
mutation! hotspot! region! (Exons! 4E9)! had! been! sequenced.!We! found! the! p53!

















Figure( 5.4.( Validation( of( BFRMSbased( p53( pathway( activity( predictions( in(
primary(gastric(and(breast(cancers.((
A.!132!primacy!GCs!with!p53!mutation!hotspot!(exons!4E9)!sequence!information!
were! grouped! according! to! their!p53! status.! Averaged! p53! pathway! activation!




















(R<E0.56,! p<0.001)! and! mutated! p53! gastric! tissues! (R<E0.64,! p<0.001)! (Figure!
5.5A! and! 5.5B).! These! data! indicate! that! gastric! cancers! with! higher! EZH2!






















type! (p53! WT)! gastric! tumors! (n=105)! and! mutant! (p53! MT)! gastric! tumors!
(n=26).!Pearson!correlation!coefficients! reveal!a!significant!negative!correlation!











!!EZH2! has! been! considered! as! a! promising! potential! targets! in! cancer! therapy!
due! to! its! aberrant!upregulation! in!many! cancer! types! and! its! association!with!
tumor! progression! (155).! However,! little! has! been! implicated! about! EZH2!
pathway! in! gastric! cancer.! Since! the! identification! of! DZNep! being! the! first!
compound! depleting! EZH2! and! inhibiting! histone! methylation,! many!
investigators!have!demonstrated! the!effectiveness!of!DZNep! for! its! antiEcancer!
activity! in! various! cancer! types.! Emerging! data! suggest! that! subsets! of! tumors!
are! likely! to! respond! to!DZNep! in! a! heterogeneous! fashion! (176,! 192,! 203).! In!
addition,! different! tumors! are! likely! to! respond! through!different!mechanisms.!
These!observations!raise!the!need!to!identify!specific!biomarkers!that!can!predict!
which! subsets! of! cancer! patients! might! benefit! most! from! EZH2Etargeted!
therapies.! Knowledge! of! these! biomarkers!might! shed! light! on!mechanisms! of!
DZNep! activity! in! primary! clinical! specimens,! and! facilitate! the! appropriate!
selection!of!patients!into!clinical!trials!evaluating!EZH2Etargeting!agents.!!
In!this!section,!I!will!illustrate!the!implication!of!EZH2!pathway!in!gastric!cancer,!
compare! the! DZNep! effects! in! gastric! cancer! to! other! cancers;! discuss! the!















As!discussed! in! introduction!chapter,!gastric!carcinomas! (GC)!are!classified! into!




Mattioli! E! et+ al.! showed! that! intestinal! gastric! cancer! expressed! higher! EZH2!
protein! level! compared! with! diffuse! GC! tissues! by! immunohistochemistry!
method! (201).!We!showed!the!genetic!expression!distributions!of!EZH2!and! its!
related! SUZ12! and! EED! in! each! of! the!GC! subtypes.! Our! gastric! cancer! tissues!
consisted!of!74!diffuse!and!99! intestinal!GC!and,!on!average,!EZH2,!SUZ12!and!
EED! were! expressed! at! a! higher! mRNA! level! in! intestinal! GC! compared! with!
diffuse!GC!(p≤0.002).!!
Apart! from! EZH2,! SUZ12! and! EED,! approximately! less! than! 5%! (<1000)! genes!
among! ~25000! genes! in! the! genome! showed! similar! unequal! distribution!
between! two! types.!This! could! reflect!genetic! variation!between! these! two!GC!







that! led! to! more! aggressive! and! metastastic! feature! of! diffuse! cancer! (237)!
whereas,! Cal! GH.! et+ al.,! displayed! progressively! increasing! EZH2! protein!
expression!along! the!multiEstage!development!of! intestinal!GC! (238).! This!data!
implies! that! the! oncogenic! function! of! EZH2! may! contribute! to! intestinal! GC!
development! by! histone! dependent! or! independent! mechanism.! Higher! EZH2!
expression! in! intestinal! GC! may! also! contribute! to! its! feature! of! higher!
proliferation! rate,! which! was! identified! by! Zheng! H.! et+ al.,! using!





breast,! acute! myeloid! leukemia,! multiple! myeloma,! prostate,! lung,! brain,!
embryonic!teratocarcinoma!and!mesothelioma! ! in+vitro!and! in!some!reports,! in+
vivo+(188,!190,!191,!202,!203,!240E242).!They!found!some!cancer!cells!lines!were!
refractory! to! DZNep! treatment! (191,! 192,! 202).! For! those! cells,! which! were!
sensitive! to! DZNep! treatment,! in! general,! DZNep! caused! apoptosis! to!most! of!
them.!However,!Crea!F.!et+al.! and!Hayden!A.!et+al.! showed!some!prostate!and!
breast!cancer!cells!responded!to!DZNep!by!growth!inhibition!together!with!DNA!
content!changes!but! there!was!no!significant!apoptosis!detected! (188,!191).! In!








that! DZNep! response! could! be! tissue! specific,! depending! on! possibly! unique!
genetic!and!epigenetic!profile!of!each!cancer!type!and!even!each!cancer!cell!line.!
The!tissue!specific!response!of!DZNep!could!be!further!supported!by!comparing!




molecular!mechanisms!of!DZNep!effects!by! identifying! the!differential!genes! in!
each! gastric! cancer! cell! line! upon! DZNep! treatment.! In! the! future,!microarray!
experiment! could! be! performed! in! three! sensitive! and! three! resistant!
representatives! after! DZNep! treatment! at! 6! hours! and! 48! hours! in! order! to!
understand!profiles!of!DZNep!targets!at!various!times!of!treatment.!
!!Although! Tan! J.! et+ al.! firstly! demonstrated! DZNep! depleted! EZH2! associated!




specificity! of! a! EZH2! targeting! siRNA! sequence! by! conducting! a! rescue!
experiment! (195).! In! our! study,! treatment! with! this! validated! EZH2! siRNA!








They! demonstrated! early! changes! in! DNA! content,! SubG1! increases! and!




!!Heterogeneous! DZNep! responses! were! reported! in! breast! and! multiple!
myeloma! cells! (192,! 243).! One! model! explaining! why! DZNep! can! uniformly!
induce!EZH2!and!H3K27me3!depletion!in!all!lines,!but!cellular!responses!in!only!a!
subset!of! lines,! is! that!the!molecular!determinants!regulating!the! latter!may! lie!
downstream! of! EZH2.! Puppe! J.! et+ al.! suggested! BRCA1Edeficient! breast! cancer!
cells!are!sensitive!to!DZNep!due!to!its!dependency!to!EZH2!(192).!Whereas,!Xie!
ZG.!et+al.!suggested!another!EZH2!independent!model!where!depletion!of!ALOX5!
regardless! of! EZH2! function! was! responsible! for! DZNep! sensitivity! in! multiple!
myeloma!(203).!This!may!suggest!DZNep!influences!different!cancer!differently.!
In! this! regard,! our! most! significant! finding! was! the! discovery! of! a! highly!
significant! relationship! (P<0.001)! between! p53! genomic! status! and! DZNep!














YCC3! is! likely! caused! by! reactivation! of! proliferationErelated! genes! in! a! p53E
independent!manner.!Fan!T.!et+al.! found!that!EZH2! inhibited!p21!expression! in!
melanoma!cells! in!p53! independent!manner! (245).!Their! finding!also! implicates!
the!possibility!that!DZNep!could!activate!genes!in!YCC3,!such!as!p21,!which!are!
normally! epigenetically! repressed! by! either! EZH2! or! other! epigenetic!
machineries.!Whereas,!YCC16!harbored!wildEtype!p53,!however!it!was!resistant!




for! promoter! binding.! Muller! M.! et+ al.! showed! increased! levels! of! DNp73!
proteins!confer! to! liver!cancer!cells! resistance! to!apoptosis!and,! irrespective! to!
p53! status,! a! chemoresistant! phenotype! (246).! Recently,! Vilgelm! AE.! et+ al.!
showed!some!gastric!cancer!tissues!have!higher!deltaNp73!expression!compared!
with! normal! tissues! (247).! Thus,! it! could! be! possible! that! YCC16! may! highly!







!!p53! activation! can! result! in! the! activation! of! downstream! target! genes! in! a!
tissueEspecific! manner! leading! to! cell! cycle! arrest,! senescence,! and! apoptosis.!
These!phenotypes!mirrored!our!DZNep! treatment! results,! and! in!our! study!we!
confirmed!that!DZNep!treatment!and!EZH2!silencing!can!both!stabilize!p53!and!




Fan! et+ al.! reported! that! EZH2! knockdown! can! activate! p21,! albeit! in! a! p53!
independent!manner,! in!melanoma! (248).! In! osteosarcoma,! ! EZH2! knockdown!
does! not! stabilize! p53! nor! activate! p21,! and! may! instead! transcriptionally!
reactivate!a!p21!regulator!which!directs!p21!degradation!(244).!!!In!breast!cancer!
study,! Pietersen! AM! et+ al.! reported! a! positive! correlation! between! high! EZH2!
expression! and! p53! mutation! status! in! breast! cancer! (249),! and! an! increased!
sensitivity!of!BRCA1Edeficient!breast!tumors!(usually!associated!with!p53!loss!but!
high! EZH2! expression)! to! DZNep! (192).! In! a! preliminary! analysis,! we! applied!
BFRM! analysis! to! 251! breast! tumors! from! public! access! data! (194).! Pearson!
correlation!revealed!an!!insignificant!correlation!between!p53!activity!and!EZH2!
expression!levels!in!p53!wildEtype!breast!tumors!(Figure!6.1A)!but!very!significant!
negative! correlation! in!p53!mutant!breast! tumors! (Figure!6.1B).! These! findings!







also! confirmed! the! analytical! power! of! BFRM! using! KANNA! signature! on!
modeling!p53!activity.!!Taken!together,!the!effects!of!DZNep!treatment!and!EZH2!




























Figure( 6.1.! Relationship( between( EZH2( RNA( expression( and( p53Spathway(
activity.(
!Pearson!correlation!coefficients!reveal!an!insignificant!correlation!between!EZH2!

















this! was! the! most! commonly! known! pathways! regulating! p53! ubiquitination.!
Surprisingly,! DZNep! did! not! induce! significant! DNA! damage! or! p53!
phosphorylation,! which! could! dissociate! MDM2! from! p53! (Figure! 4.8).! This!
observation! is! supported! by! Musch! T.! et+ al! who! also! showed! DZNep! had! no!
effect! on! γH2AX! in! human! embryonic! teratocarcinoma! (242).! However,! to!
completely! rule! out! the! possibility! of! the! involvement! of! DNA! damage! signal,!
genetic!inhibition!of!ATM!and!ATR!could!be!performed.!In!addition,!we!observed!
no! protein! induction! of! MDM2! antagonist,! p14ARF! in! two! representative!
sensitive!cell!lines.!!Although!p14!is!regulated!by!EZH2!in!mouse!fibroblast!cells,!
EZH2! lost! its! control! on! p14! transcription! in! human! fibroblast! cells.! ! In! cancer!
cells,! p14! is! associated! with! high! DNA! methylation! (250).! Our! result! may! not!
firmly!exclude!the!possibility!that!p14ARF!involvement!may!have!contributed!to!
MDM2!function!inhibition!(251).!Bracken!AP.!et+al.!showed!that!EZH2!knockdown!






amount!of!p14ARF! is! sufficient! to!affect!cell!growth! in! fibroblast!BJ!cells! (160).!
Our! preliminary! data! also! showed! no! significant! p14! induction! upon! DZNep!
treatment! in! AGS! cells! (Figure! 4.7B).! However,! I! think! any! possible! slight!
induction! of! p14! mRNA! could! not! be! able! to! lead! to! the! drastic! p53! protein!







DZNep! effects! on! p53! stabilization.! Since! their! mRNA! inductions! upon! DZNep!
were!mild,!we!further!validated!their!expressions!in!protein!levels.!By!examining!
and! comparing! the!protein! expressions! of!NUMB!and!USP10,! and!p53! at! early!
time! points,! our! data! showed! NUMB! and! USP10! increased! significantly.! The!
protein! induction!of! these!genes!happened!before!p53! stabilization! (Figure!4.8!
and!4.13).! !One!possible!explanation! for! the! rapid!upregulation!may! lie!on! the!
histone! methylation! features! on! gene! promoters.! ! Berger! SL.! proposed! the!
bivalent! modificationsEcoexisting! repressive! H3K27me3! and! active! H3K4me3E!
repress! expressions! of! development! genes! in! embryonic! stem! cells! (ESCs)! but!







expression!within! 3! hours! of! treatment! (253).! Although! no! report! investigated!





!!Recently,! investigators! reported! lysine! methlyation! on! p53! protein! could!
influence! the! protein! stability! and! transcriptional! functions! of! p53! (254).!
Different! lysine! methylation! modifications! confer! distinct! effects! on! p53.! For!
example,! Set9! stabilizes! and! activates! p53! by! monomethylation! at! lysine! 372!
(255),!in!contrast,!Smyd2!suppresses!p53!function!by!monomethylation!at!lysine!
370!(256).!Moreover,!Set!8!enzymatic!activity!monomethylates!lysine!382,!which!
suppresses! p53Emediated! transcription! activation! of! highly! responsive! target!
genes!(257).!Noteworthy,!EZH2!is!a!protein!carrying!Set!enzymatic!domain.!I!will!
not! exclude! the! possibility! that! reduced! expressions! of! EZH2! by! DZNep! may!
attenuate! the! inhibitory! lysine!382!methylation! in!a!nonEhistone!manner,! thus,!
leading! to! p53! activation! or! confer! a! direct! activated! nonEhistone! lysine!
methylation! on! p53! protein.! Immunoprecipitation! experiment! could! be! done!
using!antibodies!specifically!targeting!p53K382me1!or!panEp53!lysine!to!explore!
any!related!changes!upon!DZNep!treatment.!!
!!There! are! some! other! mechanisms,! which! could! possibly! lead! to! p53!







apart! from!nucleus! in! several! cell! types! including! thymocytes! and!peripheral! T!
cells!but!not!HEKE293!cells!(179).!They!showed!that!cytosolic!EZH2!contributed!to!
actin!polymerization.!Another!report!demonstrated!that!EZH2!knockdown!in!PC3!
prostate! cancer! cells! increased! the! amount! of! FEactin! polymerization,! cell! size!
and!the!formation!of!actinErich!filament!(258).!No!other!extracurricular!activities!
of! cytoplasmic! EZH2! were! reported.! To! explore! if! depletion! of! nuclear! or!
cytoplasmic! EZH2!may! contribute! to! the!p53! stabilization! in! gastric! cancer,!we!
could!examine!the!distribution!of!EZH2!protein!in!different!cell!fractions.!If!there!




its!N! terminus,! could! reEintroduce! cytosolic! EZH2!but! not! nuclear! EZH2.!Under!
this! circumstance,! DZNepEinduced! p53! stabilization! will! implicate! the!













!!However,! regardless! of! the! actual! mechanism! of! DZNepEmediated! p53!
















wildEtype! gastric! tumor! samples! as! well! as! in! mutant! gastric! tumor! sample!
(Figure!5.5A!and!5.5B).! It! is!known!that!some!p53!mutants! retain! the!ability! to!











However,! we! were! not! able! to! identify! any! significant! correlation!
between!EZH2!and!USP10/NUMB!and!between!USP10/NUMB!and!predicted!p53!
activities! in! patient! samples.! This! may! be! probably! due! to! the! homogeneous!
nature!of!cell!lines!than!the!patient!samples!(heterogeneous).!Although!EZH2!has!
a!negative!correlation!with!p53!in!patient!samples!supporting!our!hypothesis,!it!
may!not! follow! the!USP10!activation!pathway!and! there! could!be!other! target!
affecting!the!p53!suppression!by!EZH2!in!gastric!cancer!tissues.!However,!at!this!





In! conclusion,! our! results! provide! evidence! that! sensitivity! of! the! EZH2!
inhibitor,! DZNep,! in! gastric! cancer! (GC)! cells! is! significantly!modulated! by! p53!
activity.! GC! cells! harboring! wildEtype! p53! tended! to! be! sensitive! to! DZNep!
treatment,!while!GC!cells!that!were!p53!mutant!were!resistant.!Upon!exposure!
to!DZNep,!EZH2!is!depleted!and!ubiquitination!of!these!wildEtype!p53!proteins!is!






pathways! involved! in! apoptosis,! cell! cycle! arrest,! and! senescence! (Figure! 6.2).!
The!ability!of!EZH2,!when!highly!expressed,!to!suppress!the!activity!of!p53!may!
be!one!novel!mechanism!by!which!EZH2!promotes!gastric!tumor!formation!and!
progression.! Our! results! suggest! that! GCs! that! are! p53Emutated! are! more!
resistant!to!DZNep.!However,!p53!is!mutated!in!only!~50%!of!gastric!cancers!–!as!
such,!a!substantial!fraction!of!GC!patients!may!be!potentially!targetable!by!EZH2!
























Upon! DZNep! treatment,! EZH2! is! depleted! and! p53! ubiquinitation! is! reduced!
resulting! in!p53! stabilization,!possibly!mediated!by!NUMB/USP10!upregulation.!
Stabilized! p53! then! activates! downstream! p53! target! genes! culminating! in!
apoptosis,!growth!arrest!or!senescence.!

















!!!!!!!!!This! study! has! demonstrated! the! DZNep!molecular! determinant,! working!
mechanism!in!gastric!cancer.!We!have!also!proposed!the!possible!regulatory!role!





!!!!!!!!!Our! bioinformatic! and! statistical! analysis! suggest! a! potential! negative!
regulation! of! high! EZH2! levels! in! gastric! cancer! in! suppressing! the! p53! activity!
(Figure.! 5.7).! To! prove! this! hypothesis,! we! will! first! knockdown! endogeneous!
EZH2!in!wildEtype!p53!cell! lines!as!there!is!no!truly!normal!gastric!epithelial!cell!
line! for! culture! and! no! known! gastric! cancer! cell! lines! with! EZH2! deletion.! A!
rescue! experiment! will! be! performed! with! the! inducible! EZH2! expressing!
construct!for!investigating!specific!EZH2!overexpressing!effects.!!
((((((((((Using!this!engineered!model,!we!will!confirm!the!EZH2!siRNA!effects!in!this!
study.! Moreover,! we! will! investigate! EZH2! overexpression! effects! on! p53!
ubiquitination,! stabilization! and! also! activation.! Ubiquitination! assays! will! be!
performed! to! investigate! any! p53! protein! expression! as!well! as! ubiquitin! level!
changes!after!EZH2!overexpression.!Luciferase!reporter!assay!in!which!luciferase!



















exploring! the! phenotypic! effects! of! coEtreating! gastric! cancer! cells! with! both!
DZNep!and!NutlinE3.!
!In! addition,! H3K27! methylation! is! working! with! other! epigenetic! machineries!
such!as!histone!acetylation!and!DNA!methylation.!Some!EZH2!target!genes!may!
not! be! able! to! be! reactivated! by! DZNep! treatment! alone.! We! would! like! to!
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